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Understanding how cancer cells survive, invade and migrate is of 
fundamental importance to the development of approaches to 
inhibit invasion and metastasis in patients.  Proteins recruited at 
adhesion complexes, known as the adhesome, are involved in 
multiple mechanisms which control cancer cell behaviour.  Here, 
we used a proteomic and network analysis approach to perform a 
global assessment of functional molecular units associated with 
cancer cell progression in the context of the adhesome. We 
present the functional modules of the adhesome at different 
stages of human cutaneous squamous cell carcinoma (SCC) 
progression.  From the network analysis, we found that exportin-1, 
a mediator of protein export from the nucleus to the cytoplasm, is 
an important hub during cancer progression.  Interestingly, one of 
the interactors of exportin-1 is the actin-regulator Mena.  We 
found that Mena has a nuclear function in metastatic SCC cells 
and that the nucleocytoplasmic shuttling of Mena is regulated by 
integrin activation and focal adhesion kinase (FAK).  Moreover, 
our preliminary results suggest that Mena may act as a molecular 
clutch for the mechanosensing function of Nesprin-2 with actin.  
The putative molecular clutch activity of Mena regulates the 
 vi 
phosphorylation of EMERIN and possibly affects histone 
methylation.  Here, we propose a novel mechanism by which 





Cancer cells have the ability to move to other parts of the body in 
a process called metastasis, which is responsible for 90% of 
cancer deaths.  Understanding how cancer cells undergo 
metastasis is fundamental for the development of drugs which 
would stop metastasis.  Cells are surrounded by a scaffold in the 
body named the extracellular matrix.  The interaction between 
cancer cells and the extracellular matrix leads to the recruitment 
and assembly of small parts of a bigger machine called the 
adhesome.  These small parts are protein molecules that together 
form the adhesome machine that regulates metastasis.  We used 
patient-derived cutaneous squamous cell carcinoma cells to 
understand the molecular detail of the adhesome.  Here, we found 
that a small piece of the machinery, called Mena, goes to the 
nucleus of metastatic cancer cells and acts as a clutch to connect 
the skeleton of the cells to the nucleus.  Our results show that this 
clutch function of Mena is important in enabling the nucleus to 
sense its surrounding mechanical cues.  This allows the nucleus 
to activate its own machinery, part of which is called EMERIN.  
The nucleus also responds by inhibiting genes though a chemical 
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<Introduction 
Cell-matrix adhesions are crucial for the invasion and metastasis of 
malignant cancer. The cell-matrix adhesions are mediated by adhesion 
receptors such as integrins, which initiate and modulate signalling pathways 
via multiprotein complexes at adhesion sites.  These consist of scaffolding, 
signalling and cytoskeletal proteins, which are recruited to the cell-matrix 
interaction site thereby making up the adhesion complex.  It is known that 
adhesome signalling pathways control proliferation, survival, differentiation, 
migration1 and drug tolerance2.  However, despite numerous advances in the 
field of metastasis and invasion, changes in the adhesome during cancer 
progression are poorly characterised.  How are adhesome proteins precisely 
controlling cellular functions during cancer progression? Which adhesome 
proteins are important and what are their roles during cancer progression?  
To address those questions, the adhesome was isolated from malignant 
keratinocytes of primary and metastatic squamous cell carcinoma and 
analysed using a proteomic and network analysis approach to define 
functional molecular units associated with cancer cell progression.  It has 
previously been reported that oncogenic stress results in the shuttling of 
adhesion proteins such as focal adhesion kinase (FAK) to the nucleus3,4.  
Moreover, globular actin has also been reported in to be in the perinuclear 
region5, though the precise function of perinuclear actin is yet to be defined.  
Interestingly, we found that actin regulating protein Mena is at the outer 
nuclear membrane in metastatic keratinocytes though further work is 
required to define its role there. 
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<Adhesion Proteins 
Focal Adhesion Activation 
Focal adhesions are sites of integrin-mediated cell attachment to the 
extracellular matrix (ECM), linking the latter to the actin cytoskeleton.  
Integrin receptors are ab heterodimers capable of undergoing conformational 
change allowing bidirectional signalling events, termed ‘inside-out’ and 
‘outside-in’ signalling, across the plasma membrane6.  Integrin attachment to 
ECM has been suggested to be initiated by an ‘inside-out’ signalling event 
whereby talin binds to the integrin cytoplasmic tail resulting in a 
conformational change of the integrin from an ‘inactive’ state to a fully ‘active’ 
state6.  In the ‘active’ state, integrins have a high affinity for ECM ligand.  
Ligand binding triggers an ‘outside-in’ signalling event initiating integrin 
clustering and recruitment of focal adhesion proteins consisting of scaffolding 
proteins (e.g. VASP, p130Cas), kinases (e.g. Src, Focal Adhesion Kinase 
(FAK)), cytoskeletal proteins (e.g. actin), phosphatases (e.g. PTP-PEST, 
PTEN), GTPases (e.g. RhoA, Rac1), proteases (e.g. calpain) and ligases 
(e.g. E3 ubiquitin ligase Cbl).  This recruitment produces multiple protein-
protein interactions at the focal adhesion sites thereby allowing the cell to 
construct signalling complexes regulating diverse cell behaviours7.  In cancer 
cells, aberrant activation of integrins and adhesion proteins triggers multiple 
events such as tyrosine (Tyr) phosphorylation, serine threonine (Ser/Thr) 
phosphorylation, actin re-organization, mechanosensing and 
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mechanotransduction leading to tumour cell proliferation, invasion and 
metastasis as discussed below. 
Tyrosine Phosphorylation at Focal Adhesions Triggers 
Multiple Cell Signalling Pathways 
Tyrosine phosphorylation is a key event at focal adhesions, mediated by a 
range of non-receptor tyrosine kinases such as FAK, Src family kinases 
(SFKs), c-Abl and Pyk2. 
 
Integrin activation allows the cytoplasmic tail of the integrin b-subunit to 
relieve FAK of its autoinhibitory FERM domain, resulting in FAK 
autophosphorylation at Tyr-3978.  The binding of Src SH2 domain to the 
phosphorylated Tyr-397 residue (pTyr-397) of FAK, and the binding of Src 
SH3 domain to FAK, relieves Src of its autoinhibitory fragment.  This results 
in the activation of Src which further phosphorylates FAK at Tyr-576 and Tyr-
577 to fully activate FAK.  The FAK-Src complex recruits and phosphorylates 
the adaptor protein p130Cas at the focal adhesions9,10, which results in its 
subsequent interactions with members of the Crk scaffolding protein family10.  
Src, with its tight association with FAK, also phosphorylates paxillin at Tyr-31 
and Tyr-118, creating binding sites for Crk11.  Crk interactions with 
phosphorylated paxillin and phosphorylated p130Cas have been implicated 
in integrin-mediated cell motility11.  However, whether paxillin and p130Cas 
synergize to mediate cell motility is unclear, as it has been reported that both 
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exert opposite effects on haptotactic cell motility when either is 
overexpressed in certain cells12. 
 
The p130Cas-Crk and the FAK-Src complexes interacts with the Rho-family 
GTPases and guanine nucleotide exchange factor (GEF)- family members to 
mediate cell migration and cell invasion.  Downstream effectors of the 
p130Cas-Crk complex include the Rho-family GTPase Rac1 and GEF-family 
member DOCK180, whose activation leads to increased expression of 
metallopeptidase 2 (MMP2) and metallopeptidse 9 (MMP9) via Jun kinase 
(JNK) activation13 and lamellipodia formation14, thereby promoting cell 
motility and cell invasion (Figure 1).  FAK activates p190RhoGEF and 
PDZRhoGEF (Figure 1) leading to Rho GTP loading7, resulting in 
downstream activation of the formin family protein mDia which serves as an 
actin nucleator and facilitates actin polymerization required for cell 
migration7,15,16.  Moreover, the p85 subunit of phosphatidylinositide 3-kinase 
(PI3K) interacts with FAK at the phosphorylated Try-397 residue to promote 
cell migration17, possibly via members of the Rho family GTPases18. 
 
Integrin-induced mitogenic signals are transduced by the FAK-Src complex.  
Src phosphorylation of FAK at Tyr-861 and Tyr-925 allows FAK interaction 
with Grb2 (Figure 1), thereby linking FAK to the mitogenic Ras-MAPK 
pathway7.  Moreover, the p130Cas-Crk complex induced by FAK activates 
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the mitogenic Rac1-Ras-MAPK signalling pathway (Figure 1), which 
activates JNK, leading to cell cycle progression and promoting tumour 
growth10,19.  Furthermore, FAK activation of the PI3K/Akt pathway has been 
reported to inhibit apoptosis20 (Figure 1). 
 
 
Figure 1 Schematic diagram of FAK-Src and p130Cas/Crk complexes at the focal 
adhesion with the downstream effectors to regulate molecular processes such as cell 
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As discussed above, the FAK-Src and the p130Cas/Crk complexes are 
recruitment sites for focal adhesion protein tyrosine phosphorylation.  
Unsurprisingly, dephosphorylation by means of phosphatases is an essential 
regulatory mechanism at focal adhesions.  The deactivation of 
phosphorylated p130Cas is mediated by PTP-PEST, which is recruited to 
focal adhesions by the LIM domain of paxillin11.  Overexpression of PTP-
PEST leads to reduced level of phosphorylated p130Cas at focal adhesions 
and reduced cell migration21.  The dephosphorylation of p130Cas by PTP-
PEST has also been implicated in focal adhesion disassembly.  PTP-PEST-
ablated cells also manifest a reduced cell migration which is associated with 
an increase in the number of focal adhesions and hyperphosphorylation of 
p130Cas22.  Taken together, this suggests that the correct regulation of 
phosphorylated p130Cas by PTP-PEST is important for focal adhesion 
dynamics and turnover, both of which are important for cell migration.   FAK 
is dephosphorylated by PTEN, leading to reduced cell migration, reduced cell 
spreading and a decrease in the number of focal adhesions formed23. 
 
The FAK-Src and p130Cas/Crk complexes are also regulated through 
paxillin, consistent with its role in focal adhesion dynamics.  Non-receptor 
tyrosine kinase Csk interacts with the SH2-binding sites of phosphorylated 
paxillin in close proximity to the Src binding site.  Csk negatively regulates 
Src activity by phosphorylating the Tyr-527 (pTyr-527) residue of Src.  When 
this residue is phosphorylated, Src undergoes a conformational change 
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whereby pTyr-527 interacts with its own SH2 domain, rendering the Src 
protein catalytically inactive18.  Moreover, upon cell attachment to ECM, c-Abl 
translocates transiently from the nucleus to focal adhesions, and presumably 
associates with paxillin11,24.  c-Abl phosphorylates Crk at Tyr-221, resulting in 
the uncoupling of p130Cas/Crk complex25. 
 
Serine/Threonine Phosphorylation at Focal Adhesions 
While Tyr phosphorylation is a key element of focal adhesion functions, much 
less is known about Ser/Thr phosphorylation at focal adhesions.  Ser/Thr 
phosphorylation at focal adhesions is mediated by components of the focal 
adhesions Ser/Thr kinases such as protein kinase C (PKC) and PAK.  PKCs 
are involved in the assembly and disassembly of, and in the activation of the 
mitogenic signalling cascade at, the focal adhesions26.  Classical PKC 
consists of the α, βI, βII and γ isoforms.  PKCa is activated by the integrin-b 
co-receptor syndecan-4 complexed with phosphatidylinositol 4,5-
bisphosphate (PtdIns4,5P2), the latter being essential for the recruitment of 
PKCa and vinculin to focal adhesions26.  PtdIns4,5P2 exposes a docking site 
for PKCa to phosphorylate vinculin, allowing the latter to bind to F-actin and 
hence connect focal adhesions with the actin cytoskeleton26,27.  PKCa also 
mediates the phosphorylation of paxillin at Ser-178 which is required for cell 
migration.  Furthermore, paxillin is also phosphorylated at Ser-188 and Ser-
190, which may involve PKC and PAK kinases11.  Paxillin Ser/Thr 
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phosphorylation was reported to be required for activation of the MAPK 
pathway11. 
Mechanosensing at Focal Adhesions 
Being at the interface between the cell membrane and ECM, it is not 
surprising that some components of focal adhesions are involved as 
mechanosensors, i.e. they respond to mechanical cues and initiate a 
biochemical response.  Integrin-ECM interactions strengthen in response to 
external forces which in turn leads to the integrin clustering15,28. 
 
The tension transmitted through the integrins promotes the binding of talin to 
integrins, thereby linking integrins with the actin cytoskeleton15.  The globular 
head domain of talin contains a FERM domain, which binds to the 
cytoplasmic tail of integrins, while the tail of talin interacts with the actin 
cytoskeleton via the C-terminal rod domain.  Increased actomyosin 
contractility results in the force-dependent separation of talin’s head and tail 
domains, exposing vinculin binding sites29.  Recruitment of vinculin at these 
sites allows p130Cas binding to vinculin via its SH3 domain.  As mentioned 
above, the SH3 domain of p130Cas also binds to FAK.  Since FAK and 
vinculin localise at different layers of the focal adhesions, the FAK-p130Cas 
or vinculin-p130Cas complexes could perform different roles15,30.  The FAK-
p130Cas complex mediates a strictly signalling complex coupled with Src 
whereas vinculin-p130Cas could be involved in the early response to force15.  
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However, it is also possible that p130Cas may be crosslinking FAK and 
vinculin in a trans- fashion by forming p130Cas homodimers, which upon 
mechanical stretching, exposes otherwise hidden tyrosine residues that are 
phosphorylated by Src family kinases31, thereby acting as a mechanosensing 
and signalling complex  
 
In addition to talin, other actin binding proteins such as zyxin and VASP also 
respond to mechanical cues.  Indeed, when fibroblasts undergo cyclic 
stretch, zyxin and VASP relocate from the focal adhesions to sites of force 
application along the actin stress fibres32,33.  Actomyosin contraction is 
required for the localisation of zyxin at these force-bearing sites where it 
recruits VASP32,34.  Zyxin interaction with VASP and a-actinin is required for 
stress fibres maintenance and repair presumably at these force bearing 
sites32,34.  Moreover, zyxin and VASP were required for actin stress fibre 
thickening, thereby reinforcing the stress fibres after cyclic stretching33.  
Zyxin was also observed to undergo nuclear shuttling after cyclic stretching 
in vascular smooth muscle cells and endothelial cells32. 
The tyrosine phosphorylation of certain focal adhesion proteins in addition to 
p130Cas described above are also susceptible to mechanical cues.  For 
instance, FAK is phosphorylated at Tyr-397 when mechanical strain is 
applied7.  Moreover, phosphorylation of paxillin at Tyr-31 and Tyr-118 is 
reduced after actomyosin inhibition by bebblistatin treatment32.  These 
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observations highlight that phosphorylation events at focal adhesions are 
intricately linked to mechanosensing. 
Moreover, mechanical tension activates Rho GEFs such as Vav2, GEF-H1 
and LARG, subsequently inducing GTP loading of Rho15.  As mentioned 
previously, activation of Rho family members leads to actin polymerization 
through the activation of mDia.  Another downstream effector of Rho is 
ROCK which activates the myosin light chain, thereby increasing the myosin-
II activity and actomyosin contractility on the actin stress fibres. 
 
Mechanical sensing is not only restricted to focal adhesions but is also 
present at the nucleus.  Mechanical stress can be transmitted from the focal 
adhesions to the nucleus via the cytoskeleton35.  The latter is connected to 
the nucleus via the LINC (linker of nucleoskeleton and cytoskeleton) complex 
which consists of the nesprins and sun proteins.  Nesprin-1 and nesprin-2 
are outer nuclear membrane proteins containing a calponin-like actin binding 
domain at the N-terminal, a central spectrin repeat domain and a KASH 
domain at the C-terminal.  Nesprin-3, which lacks the actin binding domain, 
attach to the intermediate filaments through interaction with plectin 1.  
Nesprin-1 and Nesprin-2 connect the actin filament, while nesprin-3 connects 
the intermediate filament, to inner nuclear membrane proteins SUN1 and 
SUN2 which in turn bind to the nuclear lamina.  The latter is composed of 
intermediate filaments, namely lamin A, B and C, and membrane associated 
proteins such as the LEM (lap 2b, EMERIN and MAN1) domain proteins.  
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The nuclear lamina anchors regions of chromatin known as lamina 
associated domains (LADs) and could thus be involved with regulation of 
gene transcription36,37. 
 
The physical connections between the cytoskeleton, LINC complex and 
nuclear lamina are required to couple nuclear structure and nuclear 
biochemistry to mechanical stress sensing35.  Nesprin-1 stretching results in 
the phosphorylation of EMERIN on Tyr-74 and Tyr-95 as well as stiffening of 
the nucleus38.  This force transmission to the nucleus is reported to be 
mediated by integrin associated cytoskeletal proteins since tensional force 
application on integrin also resulted in phosphorylation of EMERIN38.  
Moreover, strain exerted on keratinocytes resulted in a methylation switch 
presumably regulated by the polycomb repressive complex.  Moreover, It 
was previously reported that force is also transmitted to the nuclear pore 
complex presumably via the LINC complex, thus regulating the Yap nuclear 
import/export39. 
 
Though much is known about the requirement of actin cytoskeleton and 
actomyosin for mechanical stress transduction to the nucleus, the 
requirement of actin regulator proteins for mechanotransduction is yet to be 
determined. 
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<Mena: An Actin Regulator in Cancer Progression 
Mena is a member of the actin regulator Ena/VASP protein family40.  Other 
members of the Ena/VASP proteins family are Evl and VASP, Mena being 
the mammalian orthologue Ena40.  The members of the Ena/VASP protein 
family share three conserved domains: EVH1 domain at the N-terminal, 
EVH2 domain at the C-terminal and a proline-rich region between the EVH1 
and EVH2 domains (Figure 2).  An additional domain consisting of LERER 
repeats, located between the EVH1 domain and proline-rich region, is unique 
to Mena40.  The EVH1 domain binds to zyxin and vinculin, which mediate the 
recruitment of Mena to focal adhesions40.  The proline-rich domain mediates 
binding to the SH3 domains of c-Abl and Src, with the former mediating the 
phosphorylation of Mena on residue Tyr-29641.  The LERER repeat domain 
has been reported to interact with a5-integrin.  The resulting Mena-a5-
integrin complex is required for the ‘outside-in’ signalling function of a5b142.  
The EVH2 domain mediates the interaction of Mena with G- and F-actin as 
well as mediating Mena oligomerisation.  Thus, the EVH2 domain 
presumably leads to F-actin bundling40,43. 
 
Ena/VASP proteins localise at the leading edge of the lamellipodia, where 
they associate with the barbed ends of F-actin and presumably antagonise 
the capping activity of CapZ40.  However, the anti-capping activity remains 
controversial44.  Moreover, Ena/VASP proteins have also been reported to 
inhibit Arp2/3-mediated actin filament branching40.  The expression of 
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FPPPP-CAAX, which recruits Ena/VASP proteins at the lamellipodial 
membrane, results in longer and less branched actin filaments there45.  This 
leads to slow but persistent protrusion of the lamellipodia45.  The recruitment 
of Ena/VASP proteins to the lamellipodia was found to be mediated via the 
EVH2 domain since Mena lacking the actin-binding site poorly localises at 
the lamellipodia43.  Furthermore, the protein Abi and WASP, which also 
localise at the lamellipodia, interacts with the EVH1 domain and proline-rich 
region of Ena/VASP proteins, respectively43.  However, whether these 
proteins are required for Ena/VASP localisation to the lamellipodia still needs 
to be determined. 
 
Figure 2 Schematic diagram showing the domains shared by members of the 
Ena/VASP protein family.  They all share the EVH1, proline-rich (pro-rich) and EVH2 
domains.  The LERER repeat domain is unique to Mena. 
 
Mena Isoforms 
Murine cell lines express four splice variants of Mena, namely Mena+, 
Mena++, Mena(s) and MenaINV (Figure 3).  Mena+ (also known as Mena-
140) is a neuronal-specific splice variant of 140kDa resulting from the 
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addition of a proline-rich region after the LERER repeat domain40,46.  Mena(s) 
is a small variant of 75kDa missing the proline-rich region.  MenaINV is a 
murine isoform of Mena containing an INV exon (previously known as the 
+++ exon), which confers a 19 amino acid residue insertion just after the 
EVH1 domain.  MenaINV was found to be upregulated in invasive murine 
adenocarcinoma cells in vivo47, and promoted transendothelial migration48. 
 
Figure 3 Schematic diagram showing the location of alternately-included (yellow box) 
or -excluded (denoted by * ) exon of murine Mena.   
 
cDNA transcripts of human Mena have been found to contain the +, ++ and 
INV exon49.  However, their expression has yet to be confirmed in human 
cells with the exception of the INV exon, which was recently found to be 
expressed in human invasive ductal carcinomas50.  The most characterised 
splice variants of Mena in human cancer cells are the hMena51,52, 
hMena11a51 and hMenaDv652 (Figure 4).  hMena is the ‘consensus’ human 
homologue of murine Mena, sharing 87% identity with the latter.  The 
hMena11a variant has an extra exon of 63 nucleotides between exon 11 and 
exon 12, resulting in the addition of 21 amino acids in the EVH2 domain.  
hMena11a is associated with epithelial phenotypes52 and p42/p44 mitogenic 
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activity51.  However, hMena11a suppresses invasion in vivo48.  The 
hMenaDv6 variant lacks exon 6, which encodes for 37 amino acids between 
the LERER repeat domain and the proline-rich domain.  hMenaDv6 
expression is associated with mesenchymal markers, such as N-cadherion 
and vimentin expression52.  Cells transfected with hMenaDv6 have an 
increased invasiveness through Matrigel52. 
 
Figure 4 Schematic diagram showing the location of alternately-included (yellow box) 
or -excluded (denoted by * ) exon of human Mena.  
 
Mena and Metastasis 
Mena expression is clinically associated with invasive cancers, regardless of 
the different hMena isoforms.  Immunohistological staining for pan-hMena 
was positive in 70% of invasive breast cancer (infiltrating ductal carcinoma)52 
and in 91% of metastatic breast cancer, compared to 9% in low-risk benign 
diseases and is undetectable in normal breast biopsies53.  Moreover, pan-
hMena expression was positively correlated with tumour size, proliferation 
index as evaluated by Ki67 staining, Her2 overexpression and cancer stage 
in breast cancer53.  Mena overexpression was also reported in synchronous 
(found at the time of primary diagnosis) and metachronous (found at the time 
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of recurrence) metastases of breast cancer, namely in lymph nodes, lung, 
bone, brain and pleura53.  Mena was overexpressed in colorectal 
adenomatous polyps with high dysplasia but was not expressed in either 
normal colorectal mucosa or adenomatous polyps without dysplasia54.  In 
colorectal carcinoma, Mena expression correlated with vascular invasion, 
tumour budding, tumour stage, Her-2 and p53 expression54,55.  Likewise, 
Mena expression was correlated with tumour grade of cervical intraepithelial 
lesion56.  Moreover, all invasive cervical squamous cell carcinomas 
overexpressed Mena56.  Despite high Mena expression is correlated with 
metastasis, the overexpression of Mena has no effect on cancer survival 
(data not shown). 
 
Numerous studies showed that MenaINV confers metastatic and motility 
properties in vivo and in vitro.  Rat mammary adenocarcinoma cells 
expressing MenaINV were reported to sensitize cells to epidermal growth 
factors (EGF), thereby promoting chemotaxis at extremely low concentration 
of EGF.  MenaINV also promoted multicellular streaming in vivo which is 
dependent on a paracrine signalling loop with macrophages48.  Moreover, 
MenaINV-expressing cells have a higher ability to intravasate and the 
presence of macrophages potentiates these cells to undergo transendothelial 
migration48,57.  Consistent with these findings, sections of human invasive 
ductal carcinomas of the breast with high immunohistological Mena staining 
were associated with perivascular macrophages48. 
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Mena has an important function in metastasis in mediating cell motility and 
cell invasion of metastatic cells.  However, it is possible that Mena has other 
unknown functions within metastatic cells.  Intriguingly, Mena was recently 
reported to regulate local translation of mRNAs in the axon of neurons 
through the interactions with RNA-binding proteins heterogeneous nuclear 
ribonucleoprotein K (HnrnpK) and Poly(rC)-binding protein 1 (PCBP1)58.  
This highlights the possibility that Mena functions beyond focal adhesions, 
actin stress fibres and lamellipodia. 
 
<An Integrative View of the Adhesome in Cancer 
Progression 
The Adhesome 
In 2001, an early literature-curated list of cell-matrix adhesion proteins 
consisting of approximately 50 proteins including ECM receptors, scaffolding 
proteins, kinases, cytoskeletal proteins, phosphatases, GTPase modulators 
and proteases, was published59,60.  Six years later, another literature-curated 
list of 156 proteins associated with integrin-mediated adhesion, termed the 
‘adhesome’, was published61.  After a further three years, the inventory of the 
literature-curated adhesome grew to 180 proteins62.  Despite the progress, it 
was acknowledged early on that the literature-curated list does not cover the 
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full repertoire of adhesion proteins, since the search for new adhesion 
proteins had, until recently, been based on candidate-based immunolabeling 
fluorescence microscopy and biochemical or immunochemical binding 
assays59.  Recently, multiple laboratories have described the systematic 
isolation and identification of components of the adhesome by mass 
spectrometry, allowing unprecedented depths of adhesome analysis63.  
These developments led to the identification of novel components of the 
adhesome64, provided new insights in the mechanosensing regulatory 
pathways of focal adhesions65,66 , and defined the role of integrin activation in 
regulating microtubule networks67.  However, a global assessment of the 
adhesion signalling during cancer progression is currently lacking. 
 
A meta-analysis of fibronectin-induced adhesome identified by mass-
spectrometry from different laboratories led to the construction of the ‘meta-
adhesome’68,69.  This consists of 2000 proteins, highlighting the complexity of 
the integrin-mediated adhesion nexus.  How does the adhesome contain so 
many proteins?  The adhesome isolation methods capture the transient 
interactions of multiple proteins with the adhesion complexes which were not 
previously appreciated by using low-throughput immunofluorescence 
microscopy.  Moreover, the focal adhesion proteins have multiple binding 
sites that can assemble in numerous ways with different proteins.   
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The execution of metastasis requires continuous interactions between the 
cell surface receptors integrins and the extracellular matrices (ECM) such as 
fibronectin, collagen IV, laminin and vitronectin70,71.  Moreover, the analysis 
of the adhesome network have previously revealed proximal and distal 
functions of the adhesion proteins to cell matrix-contacts in cancer72.  Indeed, 
there is mounting evidence that focal adhesion proteins have activities 
beyond the adhesion sites in cancer cells.  FAK for instance was reported to 
shuttle to the nucleus during tumourigenesis to mediate immune evasion4.  
LIM domain protein, paxillin and zyxin were also found to shuttle though their 
nuclear functions remain elusive. 
 
The Adhesome Proteomics 
Over the past several decades, cancer biologists have been seeking 
alterations in the cancer proteome, be they at cellular, tissue or serum level, 
in order to understand the mechanisms of cancer initiation, progression and 
metastasis73.  Proteomic analysis has been challenging due to the high 
diversity of proteins present in cells, not least due to alternative splicing 
producing a range of protein isoforms74.  Moreover, the proteomic complexity 
is further amplified with post-translational protein modifications (e.g. 
phosphorylation and ubiquitination) which affect protein dynamics and 
proteins interconnectivity in signalling networks74.  However, with the 
advancements of mass spectrometry instrumentation, sample preparation 
Understanding the adhesome network in primary and metastatic cutaneous 
squamous cell carcinoma 
Introduction 21 
and computational analysis have allowed for unprecedented depths of 
analysis in cancer proteomics73,74. 
The first step in any proteomic experiment is the protein extraction from the 
cells.  Recent advancement was made in the extraction of the adhesome 
which allowed for subsequent mass-spectrometry analysis75.  The adhesome 
was isolated from malignant keratinocytes derived from cutaneous squamous 
cell carcinoma (SCC) at the primary site and at secondary metastatic sites.  
These cell lines are referred to as the Met series and they reflect the clinical 
progression of SCC76.  The Met series is composed of Met1, which was 
derived from primary SCC, Met2, which was derived from recurrent SCC at 
the primary site and Met4, which was derived from distant metastatic SCC 
within left axillary lymph nodes. The Met series is a particularly good model 
to compare primary versus metastatic SCC. Indeed, multiplex fluorescence in 
situ hybridization (M-FISH) studies of the Met series showed that Met4 cells 
contained marker chromosomes of Met1 cells, suggesting direct evolution of 
Met4 cells from Met1 cells 77. Thus, Met1 and Met4 cell lines were used here 
to investigate potential signalling crosstalk in the adhesome that may control 
metastasis.  In order to obtain a reliable adhesome proteomics dataset, an 
adhesome isolation protocol was optimised for these cells. 
 
For proteomic analysis of adhesomes, isolated adhesion complex proteins 
undergo proteolysis into peptides, which are then analysed by liquid-
chromatography tandem mass-spectrometry (LC-MS/MS)75.  These peptides 
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are separated by liquid-chromatography (LC) and subsequently ionised and 
analysed by the first mass spectrometer (MS1)74,78. The MS1 spectra 
obtained gives information about the mass/charge ratio (m/z) and intensity of 
the peptides eluting from the LC column78.  The MS1 then isolates and 
fragments each peptide species inside a tandem mass spectrometer (MS2) 
to obtain an MS2 spectra78.  The MS2 spectra and the masses of the 
peptides from MS1 are used as inputs to identify the peptides in silico using a 
peptide sequence database search engine74.  The peptide fragments are 
assembled into proteins which are statistically validated to estimate the false 
positive identifications74.  Quantification of the proteins through spectral 
counting or signal intensity of the detected peptide is termed label-free 
protein quantification (LFQ).  LFQ provides robust and precise relative 
protein expression while being the least cumbersome way to obtain protein 
quantification74. 
 
Proteomic Data Pre-processing 
Peptide identification and quantification by label-free quantification mass-
spectrometry has facilitated high-throughput differential protein abundance 
analysis.  Putative changes in relative protein abundance in the adhesome 
are not only caused by biological change from primary tumour to metastatic 
cancer, but are also caused by systematic error and variability introduced 
during experimental procedure79,80. 
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Data normalisation aims to reduce extraneous variability and eliminates 
systematic error, both of which could introduce bias in proteomics 
analysis79,81.  Extraneous variability is introduced for instance when the 
experimental parameters differ during biological or technical replicates.  
Systematic error results for instance from unequal loading of peptide 
masses.  It is thus essential to assess multiple normalisation techniques that 
best reduces intragroup variation and eliminates systematic error. 
 
Another major challenge for differential protein abundance analysis is 
imputing missing values in label-free quantification proteomics.  Ignoring 
missing values results in loss of statistical power and introduces bias82 
(especially when missing values are not random), and hence is detrimental to 
differential protein abundance analysis.  There are multiple reasons for 
missing values, ranging from biophysical characteristics of the peptides (e.g.: 
ion suppression of the peptides, ionization competition, etc..) to 
bioinformatics mechanisms (e.g. misidentification of peptides)83 to peptide 
censoring, whereby the peptide’s abundance is below the limit of detection 
and/or limit of quantification of the mass-spectrometry instrument80.  Missing 
values are classified into three categories: 
1. Missing Completely At Random (MCAR); these are missing values 
which are independent of peptide intensity. These are caused, for 
Understanding the adhesome network in primary and metastatic cutaneous 
squamous cell carcinoma 
  Introduction  24 
instance, by stochastic fluctuations leading to misidentification of 
peptides83 or due to random sampling of peptides for identification in 
mass spectrometry84. 
2. Missing At Random (MAR); these missing values are dependent on 
the observed values82. 
3. Missing Not At Random (MNAR); these are missing values which are 
dependent of peptide intensity. These missing values are referred to 
as censored values. 
 
MCAR and MAR are also known as ‘ignorable’ missing values82.  However, 
for differential abundance analysis, ignoring MCAR and MAR has a worse 
performance than when missing values are imputed85.  Different tools have 
been developed to impute missing values83,86.  However, not all imputation 
tools have similar estimation of the missing values as they are all designed 
using different mathematical concepts.  Thus, it is important to evaluate the 
accuracy of the different imputation methods in estimating missing values.  
Webb-Robertson et al86 evaluated a range of imputation methods and found 
that the least square adaptive (LSA) method of the LSimpute87 package 
worked best for proteomics dataset in general.  However, the evaluation did 
not take into consideration the types of missing values.  Thus, a priori 
assumption that LSA is the best imputation method for proteomics dataset 
may be detrimental to downstream analysis.  A multiple imputation (MI) 
method, which considers the different types of missing values in proteomics 
data, are known to perform well.  However, in proteomic experiments, it is 
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very difficult to know the cause of missingness for proteins with missing 
values and apply the correct imputation method accordingly. 
Network Biology 
A Functional Module and Community Detection 
Proteins can interact with one another to form signalling modules that drive 
cellular functions.  The adhesome is one such signalling module of multiple 
protein-protein interactions that mediates mechanosensing and signal 
transduction.  Efforts to map the entire protein-protein interactions generated 
the interactome, with most interactions yet to be mapped74. 
 
It is becoming evident that disease-associated proteins (such as those 
differentially regulated between disease phenotypes) interact with each other 
to form modules in the interactome map, the so-called ‘disease module’88-90.  
Proteins within the disease modules (disease-specific functional modules) 
are postulated to act collaboratively to drive disease phenotypes88.  In a 
similar way, we wish to identify adhesome proteins that drive cancer 
progression and interrogate their interconnectivity.  This would lead to the 
identification of adhesome proteins driving cancer progression which may be 
targets for drug development.  Thus, using differential protein abundance 
analysis alone is not sufficient as it ignores the interaction between individual 
proteins.  Computational development in mathematical optimisation and 
network theory (also known as graph theory) has allowed new algorithms 
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which integrate differential protein abundance analysis within a protein-
protein interaction network context 91.  Such algorithms produce a network of 
differentially abundant proteins (active proteins) and their interactions with 
one another, a so-called ‘active module’ or ‘functional module’91.  We applied 
an exact approach on the adhesome network to extract an active module that 
may putatively drive cancer progression. 
 
The protein-protein interaction network is noisy and incomplete.  Thus, the 
functional module may lack an interconnected ‘clique’92 or at least a 
multipartite93 network topology expected from signalling pathways or from 
protein complexes.  Assuming that the protein-protein interactions network 
was complete, one would expect protein complexes to form a highly 
connected ‘clique’, i.e all nodes are connected to the other nodes 
(mathematically, if n nodes form a clique, each node will have n-1 edges) or 
multipartite graph.  On the other extreme, in a non-complete fragmented 
network (network where most nodes are not connected), no discernible 
network module will be observed89.  In its current state, the interactome 
allows large module to be observed but is too fragmented for small module to 
be extracted89.  Thus, different community structure algorithms were used in 
order to obtain a mesoscale view and hence the functionality of the proteins 
in the active module94,95.  The use of community structure algorithms is 
further supported by the fact that, as mentioned above, disease-associated 
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proteins are modular in nature (in other words, they tend to form community 
structures) and hence may function together to drive a disease phenotype88. 
 
Hub 
As well as understanding how proteins act collaboratively to drive a disease 
phenotype, it is equally important to identify the most essential proteins in a 
signalling complex.  In the context of a protein-protein interaction network, 
essential proteins are involved in a large number of interactions, the so called 
‘hubs’96.  The functional importance of hubs were highlighted in 
Saccharomyces cerevisiae (S. cerevisiae) whereby deletion of highly 
connected hub proteins were found to be lethal97. 
 
Han et al.98 reported two classes of hubs (hubs being defined as nodes with 
degree greater than five) based the level of coexpression between the hub 
and its interacting partners.  The level of coexpression follow a binomial 
distribution, giving rise to the dichotomy of ‘party’ and ‘date’ hubs98.   Party 
hubs are highly coexpressed with their neighbours and preferentially link 
proteins within the same community (intra-module hub)99.  Date hubs, which 
have relatively low coexpression with their neighbours, are considered as 
inter-module hubs that connect communities to each other99-101.  However, 
the dichotomy of ‘party’ and ‘date’ hubs is controversial99,102 with  Chang et 
al.99 and Taylor et al.100 showing evidence for a more complex dynamic 
architecture.  Taylor et al.100 reported a multimodal distribution of hubs 
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coexpression in human protein-protein interaction network as opposed to a 
bimodal distribution as observed by Han et al.98 for the S. cerevisiae 
interactome.  However, human protein hubs which are conserved in S. 
cerevisiae produce a binomial distribution of coexpression100, suggesting that 
the human interactome has a higher dynamic complexity than that of yeast.  
Despite the multimodal distribution in the human interactome, hubs were still 
classified into two distinct classes of ‘party’ and ‘date’ hubs. 
 
Guimera and Amaral94,103 classified hubs in terms of their structural roles 
within their respective communities.  Communities are clusters of interacting 
nodes within a network.  In protein-protein interaction network, proteins within 
a community are postulated to participate in the same molecular 
processes104.  Nodes with within-community degree (z) ³ 2.5 are considered 
as hubs.  Those hubs can be further categorised into provincial hubs, 
connector hubs and kinless hubs according to their participation coefficient 
(P).  Provincial hubs have P £ 0.30.  These hubs have a majority of their links 
within their communities. 
Connector hubs have 0.30 < P £ 0.75.  The hubs have a majority of their 
links with other communities.  Kinless hubs have P > 0.75.  These hubs have 
links homogenously distributed among all communities within the network. 
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The classification of hubs such as date and party hubs98, connector, kinless, 
and provincial hubs94,103, inter-module and intra-module hubs100,101 are not 
mutually exclusive.  Indeed, connector and kinless hubs have been reported 
to behave as date hubs, and provincial hubs as party hubs, though the 
provincial and party hub similarity was quite modest99. 
 
<Aims 
A global assessment of the functional molecular units in adhesion complexes 
that mediate cancer progression is currently lacking.  With the development 
of new methods to isolate adhesion complexes for mass-spectrometry and 
network analysis, we aim to isolate the adhesion complexes and identify by 
mass-spectrometry the adhesion proteins in patient-derived primary and 
metastatic SCC.  By performing network analysis on the isolated SCC 
adhesion proteins, we aim to better understand the molecular processes 
mediated by groups of differentially abundant adhesion proteins in primary 
and metastatic SCC cells.  We also aim to identify key adhesion hub(s) 
involved in the progression of SCC.  Together, these results will allow us to 
form hypotheses onto the role(s) of adhesion proteins during cancer 
progression and identify adhesion proteins of interest.  We aim to understand 
the functional relevance of these adhesion proteins of interest by knocking-
out their expression in patient-derived primary and metastatic SCC cells 
using CRISPR/Cas9 system.  This is complemented by immunofluorescence 
and subcellular fractionation analysis to reveal their subcellular localization.  
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Our aim is to obtain a mechanistic insight into novel roles of adhesion 
proteins during SCC cancer progression. 
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<Adhesome Isolation Optimisation 
Cell Culture 
Human cutaneous SCC cell lines Met1, Met2 and Met4 were a gift from 
Professor Charlotte Proby (University of Dundee). They were cultured as 
previously described: Dulbecco’s modified Eagle’s medium (DMEM; Sigma-
Aldrich, D 6546) and Ham’s F12 nutrient mixture (Life Technologies, 21765-
037) (3:1 ratio) supplemented with 10% fetal bovine serum (FBS; Life 
Technologies, Ref. 10270-106), 3mM L-glutamine (Sigma-Aldrich, G7513), 
and RM+ media (5 µg/ml transferrin, 0.4 µg/ml hydrocortisone, 1x10-10M 




2D global focal adhesion isolation was carried out as previously described75. 
Briefly, Met series cell lines were seeded on plates coated with 10 µg/ml 
human fibronectin (BD Biosciences, 354008) and 20 µg/ml negative control 
ligand (e.g. Apo-transferrin (gift from Dr. Adam Byron) or Poly-D-Lysine 
(Sigma Life Sciences, P6407)) and incubated for 4 hours at 37°C in 
humidified 5% (v/v) CO2. 3mM of reversible and cell permeable crosslinker 
DTBP (dimethyl-3-3’-dithiobispropioimidate; Thermo Scientific, 20665) in 
DMEM/F12 is added and incubated at 37°C for 5 minutes followed by 
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quenching with 150 ul 1M Tris-HCl for 3 minutes at room temperature. Cells 
are lysed after which the cells can either be frozen at -70°C overnight prior to 
washing procedure or washed just after cell lysis.  In the wash step, 
hydrodynamic pressure is applied with a Waterpik device (Waterpik Ultra 
Water Flosser WP120).  The adhesome proteins are subsequently isolated 
using 300 ul Adhesion Recovery buffer (125mM Tris.HCl pH6.8, 1% (w/v) 
SDS, 150mM dithiothreitol) and constituents of the isolated protein 
complexes are analysed by western blot and by Coomassie staining 
(Expedeon InstantBlue ISB1L) as per manufacturer’s protocol. 
 
The isolated adhesome complex fractions were checked for co-purifying 
nuclear (lamin A/C, Histone H4 (His H4), minichromosome maintenance 
complex component 2 (MCM2)), mitochondrial (complex IV), endoplasmic 
reticulum (calnexin) and cytoplasmic (Hsp90) contaminants. Cell lysate is 
included as a positive control only. 
 
Lysis buffers evaluation. 
Lysis buffer evaluation was performed on using Met1, Met2 and Met4.  Three 
types of lysis buffer were evaluated; a hypotonic solution of 2.5mM 
triethanolamine (TEA) in PBS; a detergent containing lysis buffer, RIPA 
(50mM Tris.HCl pH 7.5, 150mM NaCl, 5mM EDTA, 0.5% (w/v) SDS, 1% 
(w/v) sodium deoxycholate, 1% (w/v) Triton X100); and a high pH lysis buffer, 
FA extraction buffer (0.05% (w/v) NH4OH, 0.5% (w/v) Triton X100, in PBS). 
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Negative control evaluation.  
Negative control evaluation was performed as outlined in the protocol above 
except that both poly-D-lysine and apo-transferrin were used as negative 
control. 
Crosslinking incubation time evaluation. 
Crosslinking incubation time evaluation was performed as outlined in the 
protocol above except that crosslinking time was increased to 30 minutes 
while maintaining crosslinker concentration at 3mM. 
Crosslinking concentration evaluation. 
Crosslinking concentration evaluation was performed as outlined in the 
protocol above except that DTBP concentration was increased to 10mM 
while maintaining crosslinking time for 5 minutes. 
Choice of crosslinker evaluation. 
This evaluation was performed as outlined as above except that 
dithiobis[succinimidyl propionate] (DSP) and 1,4-di-[3′-(2′-pyridyldithio)-
propionamido] butane (DPDPB) were used as crosslinker instead of DTBP. 
DSP and DPDPB were dissolved in 1% DMSO in PBS. Concentrations of 
3mM DSP with 0.2mM DPDPB and 3mM DSP with 0.05mM DPDPB were 
used. 
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Adhesome isolation from human cutaneous squamous cell carcinoma was 
analysed by tandem liquid chromatography mass spectrometry (LC-MS/MS).  
The raw files were analysed by MaxQuant.  Peptides were identified against 
the UniProt human database (UP000005640_9606) using the Andromeda 
search engine.  Oxidation of methionine and acetylation of the N-terminal 
was allowed as variable modification and carbamidomethylation of cysteine 
as a fixed medication.  The dataset consists of protein intensities for 3 
replicates per condition (primary (Met1) and metastatic (Met4)).  The 3 
replicates were numbered 1-3 (e.g. Met1 Replicate 1, Met1 Replicate 2, …, 
Met4 Replicate 1, … and so on). 
 
Filtering 
Proteins with reverse sequences and potential contaminants were removed.  
Proteins which have been detected in only one replicate or only present once 
in either primary or metastatic adhesome proteomics dataset were removed. 
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Normalisation 
Normalyzer105 was used to evaluate different normalisation methods.  Before 
normalisation, all LFQ intensities were log2 transformed.  From this point 
onwards, log2 transformed LFQ intensities are referred to as simply LFQ 
intensities unless described otherwise.  Normalisation by total intensity (TI), 
median intensity (MedI), average intensity (AI), quantile, Variance stabilising 
normalisation (VSN), robust linear regression (RLR) and cyclic LOESS 
normalisation were assessed.  These normalisation methods were applied 
globally (denoted by G), i.e the whole dataset was normalised at once.  VSN, 
RLR and LOESS were also applied locally (denoted by R), whereby the 
condition group are normalised separately. 
 
Total Intensity, Median Intensity and Average Intensity Normalisation 
Total intensity, median intensity and average intensity normalisation centre 
the protein abundance around the sum, median and average of the 
population of protein intensities from each replicate.  The intensities of each 
protein are multiplied by a scaling factor such that total protein intensity, 
median protein intensity and average protein intensity for each replicate are 
equal.  These normalisation techniques adjust for systematic error which 
occur due to unequal loading of peptide mass into the LC-MS/MS system79.  
However, these normalisation techniques assume that most protein 
abundances do not change80. 
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Quantile normalisation transforms the protein intensities distribution in each 
replicate into similar distribution79,81.  Briefly, the quantile normalisation 
approach is as follows106: 
1) In each replicate, sort by protein abundance value (from highest LFQ 
intensity first to lowest LFQ intensity in each replicate, irrespective of 
the protein). 
2) Find the mean value of the highest protein intensities. 
3) The highest protein intensities in each replicate is substituted for that 
mean value. 
4) Find the next highest protein intensities and substitute their value by 
their mean.  This is repeated until all protein intensity values have 
been substituted. 
 
This approach allows the condition groups to have the same quantile81. 
Variance Stabilising Normalisation 
The variance in intensity measurements are associated with measurement 
error.  It is important to model intensity variance in order to properly assign 
statistical significance to changes in protein abundance at different 
conditions107.  It has been suggested that in LC-MS, the variance follows a 
quadratic function of the mean intensity108.  Thus, variance stabilising 
normalisation (VSN), which was designed for microarray analysis whereby a 
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quadratic variance model was assumed107, was applied to raw protein 
intensity from LC-MS/MS. 
 
VSN transforms the raw protein intensities with a set of parametric 
estimations such that the transformed protein intensities are approximately 
independent of the variance. 
 
Robust Linear Regression 
Robust linear regression (RLR) assumes that the measurement variation 
(systematic error) is linearly dependent on the magnitude of the protein 
abundance79,109.  The RLR approach corrects for the systematic error by 
centring the protein intensity in each replicate around the median protein 
intensity across condition groups109.   
 
RLR was applied locally and globally, denoted by -R and -G respectively.  
Global RLR fits the protein intensity value of the samples around the median 
protein intensity across the whole dataset.  Local RLR fits the protein 
intensities of the replicates within a condition around the median protein 
intensities obtained within that condition.  
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Cyclic LOESS Normalisation 
Cyclic LOESS normalisation (CL) uses the MA plot, M being the difference in 
protein intensity between two replicates and A is the average protein 
intensity, for normalisation81,110.  A regression curve is fitted in the MA plot 
using loess regression (a local regression technique which fits a curve 
instead of a line).  Ideally normalised data points between two sample runs 
would have the loess smoother line along the A axis110.  CL normalises the 
two sample runs at a time by applying a correction factor to the loess curve 
such that the latter lies along the A-axis.  For more than two sample runs, CL 
iteratively normalises all distinct pairwise combinations81,109. 
 
CL was applied locally and globally.  Global CL iteratively normalises all 
distinct pairwise combinations across the whole dataset.  Local CL iteratively 
normalises all distinct pairwise combinations across a condition group.   
Imputation 
LS_Adaptive 
LS_Adaptive (LSA) is a function of the LSImpute package87.  LSA is a local 
similarity-based imputation approach86 whereby it is assumed that proteins 
which are co-regulated will have highly correlated expression profiles.  
Briefly, given a target protein with missing value, LSA finds the 10 most 
correlated proteins to the target protein.  The missing value is first estimated 
by a weighted average of 10 single regressions between the target protein 
and the correlated proteins.  Once an initial estimate is obtained for the 
Understanding the adhesome network in primary and metastatic cutaneous 
squamous cell carcinoma 
Methods 40 
missing value, a multiple regression is then performed on the different 
sample replicates and a new re-estimate of the missing value is obtained.  
The missing value is finally imputed by a weighted average of the re-
estimated missing value and the initial estimate. 
 
Multiple Imputation 
The multiple imputation (MI) method here involves a first pass single value 
imputation (SVI) followed by a second pass of imputation by Predictive Mean 
Matching (PMM).   
SVI uses the local minimum log-intensity value across a replicate run to 
impute missing value111.  SVI was performed on peptides which had missing 
values on all replicates per condition group.  In such case, it is assumed 
those peptides are below the limit of detection of the mass spectrometry and 
thus the missing values are MNAR.  SVI was reported to perform well under 
MNAR83. 
 
The remaining missing values are assumed not to be censored and thus 
imputed using PMM algorithm which produces multiple datasets with imputed 
values.  Briefly, PMM uses a Bayesian method whereby a prior distribution of 
the regression weight between the variables is specified112,113.  The posterior 
predictive distribution of the missing values is then derived from the prior 
distribution.  Finally, imputations are drawn from this posterior density 
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distribution112,113.  To model multivariate missing values, missing values are 
imputed iteratively in a process termed as regression switching112.  The 
iteration is stopped when there is convergence to a multivariate posterior 
predictive distribution112-114.  This process is carried out m times to produce 
m complete datasets.  Each complete dataset has different estimates for the 
missing values.  The multiple complete datasets are pooled together to 
obtain the average of a quantity of interest114 (e.g. regression coefficient).  
However, since the primary goal here is to obtain the imputed values, only 
one complete dataset (out of m complete datasets) is selected. 
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Identification of a functional module was performed by means an exact 
approach using BioNet package115,116.  Briefly, differential abundance was 
performed on each protein between the Met1 (primary) and Met4 (metastatic) 
condition groups using Student’s t-test.  The p-values were converted into a 
score based on a signal-noise decomposition.  Each node is assigned a 
score corrected for FDR and thus becomes a weighted network.  Here, an 
FDR of 0.05 is used.  The problem of finding a maximum-weight connected 
subgraph (MWCS) is an NP-hard problem.  To circumvent this, the MWCS is 
transformed into a prize-collecting Steiner tree (PCST) problem.  The exact 
solution to the PCST problem is computed using integer linear programming.  
BioNet was implemented as part of an R package. 
Community Detection 
Weighted Active Module 
The edges of the functional module were weighted using the Spearman rank 
correlation. The community detection algorithms used here only use positive 
weights. Thus, the range of Spearman rank correlation coefficient was shifted 
by one integer so as to obtain positive values only.  The positive weights thus 
ranged from 0 to 2. 
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Louvain Method 
Louvain method117 makes use of the Girvan-Newman modularity118 as a 
quality function to optimise.  Girvan-Newman modularity refers to the fraction 
of edges falling within a community minus the expected fraction if the edges 
were randomly distributed118.  The Louvain method is an agglomerative 
approach consisting of two phases.  The first phase of the algorithm assigns 
a community to each node.  Therefore, initially, there are as many 
communities as nodes.  The algorithm then computes the gain in modularity 
by placing a given node into the community of the neighbouring node.  Each 
node is then placed in the community for which the gain in modularity is 
maximum.  In the second phase, each node in the derived community is 
agglomerated into a single node.  Therefore, each node in the new 
supernetwork represents a community derived from the first phase.  The 
initial phase of the algorithm is then reapplied to this supernetwork, i.e. each 
new node is clustered which results in maximal increase in modularity. This 
algorithm is stopped when no increase in modularity is observed.  Hence, 
community structures with maximal modularity are obtained.  The Louvain 
method was implemented as part of the igraph R package119. 
 
Spectral Modularity 
The Girvan-Newman modularity can also be optimised by using the spectral 
properties of the modularity matrix120.  The modularity matrix is expressed in 
terms of its eigenvalues and eigenvectors and the network is recursively 
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partitioned.  Spectral modularity was implemented as described by Mclean et 
al121. 
Infomap 
Infomap finds community structures within a network by tracking the 
information flow through the network.  A random walker is used as a proxy 
for the flow.  The flow is encoded in such a way that if the walker steps out of 
a community, the codeword gets longer.  Similarly, the longer the random 
walker stays within a group of nodes, the more likely those nodes are within 
the same community.  Hence, a ‘map equation’, which accounts for the 
frequency the random walker exits the community and the fraction of time the 
random walker stays within a community, was derived as an objective 
function to minimise.  A two-level algorithm similar to the Louvain method 
was used to minimise the map equation.  Initially, each node is assigned a 
community and hence, there are as many nodes as communities.  Each 
node is then placed in its neighbouring community and the map equation 
computed.  The nodes are placed in the communities which result in the 
largest decrease of the map equation.  A supernetwork is constructed 
whereby the derived communities form the new nodes.  To improve accuracy 
and avoid local minima, two additional algorithms, namely submodule 
movements and single-node movements, are added at the end of the core 
algorithm.  A submodule movements algorithm deconstructs each community 
into submodules.  Each submodule is then free to move between the 
communities derived from the core algorithm and placed in a new 
neighbouring community provided this results in reduction in the map 
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equation.  Single node movement works in a similar way to submodule 
movement except the community is deconstructed into single nodes which 
are then re-assigned to the neighbouring community only if a reduction in the 
map equation is observed. The network was deconstructed and 
reconstructed by submodule and single node movements 1000 times. 
 
Constant Potts Model with Surprise Maximization 
The Potts model is a statistical mechanics concept which describes the spin 
glass on a magnet.  Reichardt and Bornholdt122 reformulated the problem of 
community detection as a problem of finding the ground state of Potts spin 
glass model.  Traag et al.123,124 furthered this work and derived a Potts model 
with a tuneable resolution parameter g.  For an unweighted network, setting 
the g = 0 results in all nodes being in a single community.  Conversely, 
setting g = 1 results in each node being its own community.  Thus, it is 
essential to find the resolution parameter g for which ‘meaningful’ 
communities are obtained.  To this end, g was scanned for which the quality 
function termed ‘Surprise’ was maximum.  Surprise (S) measures of how 
unlikely a given community structure is found in a random network.  
Therefore, maximum S values lead to accurate community structure125.  
Constant Potts model with Surprise maximisation was implemented as part 
of the louvain package (https://pypi.org/project/louvain/). 
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Node Centrality Analysis 
z-P Parameter Space 
Guimera and Amaral94,103 used the concept that nodes with similar role 
should have similar topological properties with respect to the community 
structure.  The authors used two topological properties, namely, the within-
community degree z-score (z) and the participation coefficient (P) to define 
the role of a node with respect to the community structure.  Suppose a node 𝑖 
in community 𝑆, 𝑘%is the number of links node 𝑖 has to other nodes within the 
same community 𝑆, 𝑘&''' and 𝜎)* is the average and standard deviation 
respectively of the number of links over all nodes within the community 𝑆, 




The within-community degree z-score of node 𝑖, 𝑧%, measures how 
interconnected node I is to other nodes within the same community. 
The participation coefficient 𝑃% of node 𝑖 is defined as 







where 𝑀is the total number of communities in the network, 𝐿% is the total 
number of links of node I (degree of node I), and lim is the number of links of 
node I to module M.  Pi converges to one if the node I is homogeneously 
linked to other nodes within other communities in the network and to zero if 
node I is only connected to other nodes within its own community.  
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The nodes are classified as follows: 
1. For nodes with z < 2.5 (non-hubs): 
a. Ultraperipheral nodes (R1) have P £ 0.005.  These nodes have 
all their links within their communities. 
b. Peripheral nodes (R2) have 0.05 < P £ 0.625.  These nodes 
have at least 60% of their links within their communities. 
c. Non-hub connector nodes (R3) have 0.625 < P £ 0.80.  These 
nodes have a high proportion of their links with other 
communities. 
d. Non-hub kinless nodes (R4) have P > 0.80.  These nodes have 
links homogeneously distributed among all communities within 
the network. 
 
2. For nodes with z ³ 2.5 (hubs): 
a. Provincial hubs (R5) have P £ 0.30.  These hubs have a 
majority of their links within their communities. 
b. Connector hubs (R6) have 0.30 < P £ 0.75.  The hubs have a 
majority of their links with other communities. 
c. Kinless hubs (R7) have P > 0.75.  These hubs have links 
homogenously distributed among all communities in within the 
network. 
The z and P calculations were implemented using the BrainGraph R 
package. 
Understanding the adhesome network in primary and metastatic cutaneous 
squamous cell carcinoma 
Methods 48 
PageRank 
The PageRank algorithm ranks the nodes according to their importance in 
the network and assigns a numerical weighting to each node126.  The 
importance of a node is determined by the quantity and quality of 
neighbouring nodes linked to it and the node is assigned a PageRank (PR) 
value.  PageRank algorithm was used on the active module with Spearman 
Rank correlation coefficients as edge weights (negative values with range [-
1,1]).  A jumping factor (s) of 0.85 was used and sum of the PR values was 
set to 1.  PageRank was implemented using the igraph package119. 
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FAK and Mena gRNA constructs 
CRISPR-Cas was carried out as previously described127,128.  Guide 











AGCATCTCC), contain an AflII restriction site and protospacer adjacent motif 
(PAM).  The guide oligonucleotides were annealed by PCR.  gRNA cloning 
vector (Addgene plasmid no. 41824) was linearised by AflII digestion.  The 
guide oligonucleotides were annealed to the linearised gRNA cloning vector 
by Gibson Assembly reaction.  The constructs were transformed into 
chemically competent DH5a and selected on agar plates containing 
kanamycin.  Positive gRNA guides were identified by sequencing. 
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FAK and Mena CRISPR/Cas9 nucleofection 
Met1 and Met4 cells were grown to 60% confluency.  Cells were co-
nucleofected with 3µg gRNA (either FAK gRNA or Mena gRNA) and 3µg 
hCas9 (Addgene, plasmid ID 41824) using Amaxa Human Keratinocyte 
Nucleofector Kit (Lonza, #VPD-1002) according to manufacturer’s protocol.  
Briefly, cells were trypsinised into cell suspensions which were then 
centrifuged at 210 x g for 5 min.  The supernatant was aspirated and the 
cells were resuspended into 100 µl of Nucleofector solution containing 3µg 
gRNA and 3µg hCas9 and transferred to the nucleofection cuvette.  
Nucleofector was set to T-024 program.  After nucleofection, the cells were 
resuspended into RM+ media. Three rounds of nucleofection with gRNA and 
hCas9 were carried out onto the cells.  Cells were allowed to recover and 
grow to 60% confluency in between nucleofection rounds. 
Treatment 
Mena11a re-expression 
pcDNA-Mena11a was a gift from Dr. Francesca Di Modugno.  Cells were 
transiently transfected with pcDNA-Mena11a using the X-tremeGene HP 
DNA transfection reagent (Roche) according to manufacturer’s protocol.  
Cells were transfected at a ratio transfection reagent:DNA of 2:1.  Cells were 
incubated for 60 hours prior to phosphotyrosine immunoprecipitation 
experiment. 
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Leptomycin-B 
Met4 cells were treated with 10nM and 20nM Leptomycin-B (Cell Signalling 
Technology, # 9676S) and ethanol as control for 4 hours.  Cells were washed 
with ice-cold PBS three times prior to fractionation.  Cells were harvested in 
Cyto buffer (10mM Tris-HCl, pH 7.5, 0.05% NP-40, 3mM MgCl2, 100mM 
NaCl, 1mM EGTA) supplemented with protease inhibitors (1.25mM 
phenylmethylsulfonyl fluoride, 0.5mM NaF, 0.1mM sodium orthovanadate, 
0.1%(v/v) Aprotinin).  The lysate is centrifuged at 1000 x g for 10 min at 4°C.  
The supernatant (cytosolic fraction) is collected and kept for analysis.  Pellet 
is homogenised in modified RIPA (50mM Tris-HCl, 150mM NaCl, 5mM 
EDTA, 0.5% (w/v) SDS, 1% (w/v) sodium deoxycholate, 1% Triton X100) 
supplemented with protease inhibitors and centrifuged overnight at 16,000 x 
g, 4°C. 
Whole cell lysate (WCL) was obtained by harvesting the cells in modified 
RIPA buffer supplemented with protease inhibitors and centrifuged overnight 
at 16,000 x g, 4°C.  The supernatant (WCL) is collected and the pellet 
discarded. 
 
Sucrose Cushion Fractionation 
Cells were seeded on fibronectin coated plates at a density of 3x106 cells / 
15cm dish and incubated overnight at 37°C prior to fractionation.  For cell 
attachment on different extracellular matrices, cells were seeded on Matrigel, 
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fibronectin, poly-D-lysine coated plates at a density of 3x106 cells / 15cm dish 
and incubated for 4 hours at 37°C prior to fractionation. 
Nuclei Pure Prep Nuclei Isolation Kit (Sigma Aldrich, #NUC-201) was used to 
obtain nuclear and cytoplasmic fraction as per manufacturer’s protocol.  It is 
recommended to use at least four 15cm dish for fractionation.  Cells were 
washed in 10ml ice-cold PBS per 15cm dish.  500µl of Lysis solution (Nuclei 
PURE lysis buffer, 0.1% Triton X-100, 1mM DTT) supplemented with 
protease and phosphatase inhibitors (1.25mM phenylmethylsulfonyl fluoride, 
0.5mM NaF, 0.1mM sodium orthovanadate, 0.1%(v/v) Aprotinin, PhoSTOP 
tablet ()) was used per 15cm dish.  An aliquot of 700ul of the cell lysate was 
set aside for total cell lysate and cytosolic fraction.  The rest of the cell lysate 
was topped up to 10ml with the remaining Lysis solution.  To each 10ml 
sample lysate, 18ml of 1.8M Sucrose Cushion solution containing 1mM DTT 
was added, making 28ml of lysate solution.  The latter was layered on top of 
a sucrose cushion consisting of 10ml 1.8M Sucrose Cushion solution 
containing 1mM DTT in an ultracentrifuge tube (Beckman, #344058).  The 
lysate was centrifuged at 30,000 x g for 45 minutes at 4°C.  The supernatant 
is aspirated without disturbing the pellet.  The pellet is vortexed in 500ul ice-
cold PBS and transferred to a 1.5ml microcentrifuge tubes and centrifuged at 
500 x g for 5 minutes.  The supernatant is aspirated.  The pellet is 
homogenised in modified RIPA buffer supplemented with protease inhibitors 
and centrifuged overnight at 16,000 x g, 4°C.  The supernatant is kept for 
western blot analysis.  The pellet is discarded. 
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To obtain the cytosolic fraction, the aliquoted cell lysate mentioned above 
was centrifuged at 16,000 x g for 10min.  The supernatant was saved for 
western blot analysis and the pellet discarded. 
 
To obtain the total cell lysate, SDS and sodium deoxycholate was added to 
the aliquoted cell lysate mentioned above to a final concentration of 0.5% 
(w/v) SDS and 1%(w/v) deoxycholate.  The mixture is thoroughly mixed and 
centrifuged overnight at 16,000 x g, 4°C.  The supernatant was saved for 
western blot analysis and the pellet discarded. 
 
Immunoprecipitation 
For Nesprin-2 immunoprecipitation, cells were harvested in NETN lysis buffer 
(100mM NaCl, 20mM Tris-HCl, pH 7.5-8.0, 0.5mM EDTA, 0.5% (v/v) NP-40) 
supplemented with protease inhibitors.  For phosphotyrosine (PY20) 
immunoprecipitation, cells were harvested in RIPA buffer (50mM Tris-HCl, 
pH 7.5, 150mM NaCl, 1% Triton X100, 0.5% sodium deoxycholate) 
supplemented with protease and phosphatase inhibitors. 
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Cells were homogenised by 15 strokes through a 15G syringe needle.  
Homogenate was centrifuged at 16,000 x g, 4°C for 10 min.  Supernatant 
(2mg protein, exceeding 400µl) was incubated with 2ug antibody (Nesprin-2 
antibody, Abcam #ab217057; PY20 antibody; BD Transduction # 610000) 
and 7µl of Dynabeads Protein G (Invitrogen, #10003D) overnight with 
rotation at 4°C.  Beads are washed three times in 500 µl of the respective 
lysis buffer.  Immunoprecipitants are eluted by boiling in 20µl Laemmli 
sample buffer at 95°C for 10 min. 
 
Western blot 
Protein concentration is measured by Pierce BCA Protein Assay kit as per 
manufacturer’s protocol (ThermoFisher, # 23227).  Protein was 
supplemented with 5x Laemmli sample buffer to a final concentration of 0.5 – 
1.0 mg/ml and boiled at 95°C for 10 min.  Samples were separated by SDS-
PAGE gel electrophoresis using Mini-PROTEAN gels (BioRad).  Proteins 
were transferred to nitrocellulose membrane (Trans-Blot, BioRad) and 
blocked with 5% (w/v) milk in Tris-buffered saline.  Membranes were probed 
with anti-Mena (Atlas, # HPA028448), anti-p53 (Santa Cruz, # SC-126), anti-
Histone H3 (Cell Signaling Technology, #4499), anti-calnexin (Cell Signaling 
Technology, 2679), anti-lamin A/C (Cell Signaling Technology # 2032), anti-
FAK (Cell Signaling Technology, # 3285), phospho-FAK (Tyr-397, Cell 
Signaling Technology, #3283), anti-calnexin (Cell Signaling Technology, 
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#2679), anti-GAPDH (Cell Signaling Technology, #5174), anti-YAP (Cell 
Signaling Technology, # 4912). Membranes were incubated in secondary 
anti-rabbit or anti-mouse streptavidin-conjugated horseradish peroxidase 
secondary Ab (Cell Signaling Technology) and visualized using the Bio-Rad 
ChemiDoc MP Imaging System. 
 
Immunofluorescence Microscopy 
Immunofluorescence was carried as follows: 16% paraformaldehyde (Alfa 
Aesar) was added to cells still in their medium to a final concentration of 4%.  
The cells were incubated for, 15 min, at room temperature and washed twice 
with PBS.  Cells were then incubated in 0.1M glycine for 5 min.  Cells 
permeabilised with 0.2% Triton X-100 in PBS, 5 min, room temperature 
followed by washing twice with PBS.  Cells blocked with 2% BSA in PBS for 
1 hour at room temperature.  Cells were incubated with 100 µl anti-Mena 
(Atlas, # HPA028448), anti-Nesprin2 (Abcam), anti-lamin B1 (Abcam, 
ab90169), phospho-FAK (Tyr-397, Cell Signaling Technology, #3283), anti-
H3K27Me2 (Cell Signaling Technology, # 9728), anti-H3K9Me2 (Cell 
Signaling Technology, # 4658), in 2% BSA in PBS overnight at 5°C 
Incubated coverslips with 100 µl F(ab)2 secondary antibody or phalloidin 
conjugated to Alexa Fluor 488, Alexa Fluor 594 (Thermo Fisher) or Atto647N 
(Rockland) in 0.05% Tween 20 in PBS for 45 min in the dark.  Primary and 
secondary antibodies were fixed again with 4% paraformaldehyde, washed 
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with PBS, followed by incubation with 0.1M Glycine for 10 minutes.  
Coverslips were mounted onto anti-fade mounting medium fluoroshield 
containing DAPI (Sigma Aldrich).  Cells were imaged by confocal laser 
scanning microscope (Olympus FV1000), spinning-disk confocal microscopy 
(Dragonfly Andor) and N-Structured Illumination Microscopy (N-SIM, Nikon). 
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Results: Adhesome Isolation Optimisation & 
Proteomics Data Pre-processing 
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<Introduction 
Metastasis is the cause of 90% of cancer mortality and, so far, drugs against 
metastatic cancers at secondary sites have failed to improve cancer 
progression-free survival or overall survival in clinical trials129.  Understanding 
the molecular mechanisms that promote metastasis to secondary sites and 
maintain cellular metastatic growth is crucial for the development of new 
therapeutics against metastasis.  The execution of metastasis requires 
continuous interactions between the cell-surface receptors integrins and 
extracellular matrix (ECM) proteins such as fibronectin, collagen IV, laminin 
and vitronectin70,71.  These integrins-ECM interactions initiate the recruitment 
of a series of intracellular proteins to the plasma membrane to form adhesion 
complexes (the adhesion nexus), which regulate biological processes such 
as cell proliferation, survival, migration, tumourigenesis and cell invasion, all 
of which are necessary for metastasis71.  This adhesion nexus, of which the 
sum of protein components is termed the adhesome, consists mainly of 
integrin receptors and scaffolding, signalling and cytoskeletal proteins61,68,75.  
Initially, the adhseome was analysed in a candidate-based manner, mainly 
by immunoprecipitation and immunofluorescence microscopy of the 
individual components59,75.  Recently, a new methodology making use of 
liquid-chromatography tandem mass-spectrometry (LC-MS/MS) was 
developed to globally assess and identify components of the adhesome75.  
This and related methodologies have successfully been applied in numerous 
studies, and they have led to the identification of novel components of the 
adhesome64, provided new insights into the mechanosensing regulatory 
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pathways of focal adhesions65,66 , and defined the role of integrin activation in 
regulating microtubule network67. 
 
A global assessment of the adhesion signalling during cancer progression is 
currently lacking.  Thus, to understand the molecular changes of the 
adhesome in a cancer progression setting, we isolated adhesion complexes 
from malignant keratinocytes derived from human cutaneous squamous cell 
carcinoma (SCC) at the primary site and at secondary metastatic sites (more 
specifically the lymph nodes) from the same patient.  In order to obtain a 
reliable adhesome proteomics dataset from these patient-derived cells, the 
adhesome isolation protocol was first optimised and validated.  Once 
optimised, the isolated SCC adhesion complex samples were then analysed 
by LC-MS/MS. 
 
Progress in peptide identification and label-free quantification (LFQ) by mass 
spectrometry has facilitated high-throughput differential protein abundance 
analysis which in turn can be interpreted using biological network analysis74.  
Changes in relative protein abundance in the adhesome of cancer cells are 
not only caused by biological changes from primary tumour to metastatic 
cancer, but can also be caused by systematic error and noise (variability) 
introduced during experimental procedures79,80.  For example, extraneous 
variability is introduced when the experimental parameters differ between 
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adhesome isolations in biological replicates.  Systematic error is introduced, 
for instance, from unequal loading of peptide mass into LC-MS/MS.  It is thus 
essential to assess multiple normalisation techniques to identify one that best 
reduces intragroup variation and eliminates systematic error prior to 
differential abundance analysis of adhesome proteomics data. 
 
Imputation of missing protein abundance values is another challenge in LC-
MS/MS proteomics.  Ignoring missing values is detrimental for differential 
abundance analysis85 and they should therefore be imputed in the dataset.  It 
was reported that the accuracy (the number of true positives) of differentially 
abundant proteins increases when missing values were imputed85.  However, 
the mechanisms resulting in missing values should be ideally taken into 
consideration.  There are broadly two types of missingness: 1) missing 
completely at random (MCAR) which arises due to, for instance, stochastic 
fluctuations during peptide identification and quantification83, and (2) missing 
not at random (MNAR) which arises, for instance, due to the peptide’s 
abundance being below the limit of quantification and/or below the limit of 
detection of the mass-spectrometer80.  MNAR values are also referred to as 
censored values. 
 
Webb-Robertson et al.86 evaluated a range of imputation methods and found 
that the least square adaptive (LSA) method of the LSimpute87 package 
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worked best for proteomics datasets in general.  However, the evaluation did 
not take into consideration the types of missing values in the datasets and 
thus an a priori assumption that LSA will work best in the SCC adhesome 
proteomics dataset may be detrimental to downstream analysis.  Therefore, 
a multiple imputation (MI) method was used here which considers the 
different mechanisms of missing values in the adhesome proteomics data.  
The MI method was evaluated against the LSA imputation method for 
estimating log fold changes, which is used for differential protein abundance 
analysis of quantitative MS data. 
 
In this chapter, we describe the optimisation of the adhesome isolation in 
human SCC cells and the subsequent normalisation and imputation of the 
adhesome proteomics dataset.  The aims of data normalisation were twofold: 
i) reducing the extraneous variation between biological replicates due to for 
example, variations in conditions and technical random error when repeating 
the experiments, and ii) reducing bias between condition groups (i.e. primary 
vs metastatic human SCC cells).  The aim of imputation was to accurately 
capture the fold change of proteins with missing abundance values.   
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<Results 
Adhesome Isolation Optimisation 
We used cutaneous SCC cells referred to as the Met series which reflect the 
clinical progression of the disease76.  The Met series is composed of Met1 
cells, which were derived from primary SCC, Met2 cells, which were derived 
from recurrent SCC at the primary site and Met4 cells, which were derived 
from distant metastatic SCC within left axillary lymph nodes76.  Multiplex 
fluorescence in situ hybridization (M-FISH) studies of the Met series showed 
direct evolution of Met4 cells from Met1 cells77.  Hence, the Met series is a 
particularly good model to compare primary versus metastatic SCC, allowing 
us to investigate the potential signalling nexus that may control metastasis at 
the adhesome level. 
 
Previously described methods for the isolation of adhesome 
proteins65,67,75,130,131 were carried out on non-keratinocyte cells.  Hence, the 
adhesome isolation75 (outlined in Figure 5) had to be optimised for the Met 
cell lines with the aims of: 
i) obtaining an efficient yield of adhesion complexes from keratinocytes 
for proteomics study (using LC-MS/MS); 
ii) enriching known adhesome proteins (e.g. FAK, b1 integrin); and 
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iii) optimising the specificity of the adhesome isolation method for 
keratinocytes, e.g. no known adhesome proteins should be observed 
in the negative control. 
Since fibronectin is essential for the metastatic cascade132,133 and allows for 
the formation of integrin-mediated adhesion complexes, we seeded the Met 
cell lines on fibronectin to isolate the adhesome.  Briefly, the adhesome 
isolation protocol (Figure 5), with the initial conditions used in the 
optimisation process, were as follows: 
1. Met cell lines were allowed to spread on fibronectin-coated plates for 4 
hours. 
2. Adhesion complexes were stabilised in the presence of 3mM dimethyl 
3,3'-dithiobispropionimidate (DTBP) crosslinker for 5 minutes.  Excess 
crosslinker was quenched.   
3. Cells were lysed and a hydrodynamic pressure applied to remove cell 
bodies. 
4. The adhesome proteins were isolated and analysed by western blot 
and LC-MS/MS.  The isolated adhesion complex fractions were 
checked for co-purifying contaminants such as nuclear (lamin A/C, 
Histone H3, minichromosome maintenance complex component 2 
(MCM2)), mitochondrial (complex IV), endoplasmic reticulum 
(calnexin) and cytoplasmic (Hsp90, GAPDH, tubulin) proteins. 
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Key experimental conditions to be optimised in the adhesion complex 
isolation protocol, according to the authors, are the following75: 
1. The choice of the negative control. 
2. Crosslinker incubation concentration and duration. 
3. The cell disruption technique; pH vs detergent lysis buffer. 
4. Cell spreading times on extracellular substrate. 
 
Figure 5 Schematic summary diagram of the adhesion complex isolation procedure.  
Cells are seeded on plates coated with extracellular ligand (e.g. fibronectin or poly-D-
ii) Crosslinking with DTBP,
quenching using Tris
i) Seed cells on fibronectin
iv) Hydrodynamic force 
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lysine as a negative control).  Cell-permeable crosslinker is added to stabilise the 
adhesion complexes.  Crosslinker was quenched, and cells were lysed and a 
hydrodynamic pressure applied to remove cell bodies. The adhesome proteins were 
subsequently isolated and analysed by western blot and LC-MS/MS. 
 
Lysis Buffer Evaluation 
SCC cell lysis evaluation was carried out on three types of lysis buffer used 
in previous adhesion complex isolation studies: a hypotonic solution of 
2.5mM triethanolamine (TEA)65; a high-detergent lysis buffer, RIPA131; and a 
high pH lysis buffer, FA extraction buffer65. 
Evaluation of the lysis buffers was carried out on Met1, Met2 and Met4 cells 
seeded on fibronectin (FN) and allowed to spread for 4 hours.  Adhesion 
complexes were stabilised in the presence of 3mM DTBP crosslinker for 5 
minutes64,75. 
 
Isolation of adhesion complexes from cells lysed with TEA buffer recovered 
the adhesion protein FAK in Met1 and Met4 cells but to a lesser extent in 
Met2 cells (Figure 6(a)).  The non-adhesion-associated protein lamin A/C 
was also recovered in samples from Met4 cells (Figure 6(a)).  Comparison 
between RIPA and FA extraction buffer showed the latter produced a higher 
recovery yield of the adhesion protein FAK in Met1 and Met4 cells (Figure 
6(b)).  The non-adhesion-associated protein lamin A/C was present at low 
levels in samples from Met4 cells but otherwise not observed in Met1 cells 
(Figure 6(b)). 
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This evaluation suggests that FA extraction buffer was most suitable for the 
chemical disruption of human SCC cell bodies under the experimental 
conditions tested.  We subseqeuntly used FA extraction buffer for the rest of 
the adhesion complex isoaltion optimisation process.
 
Figure 6 Western blot comparison of isolated adhesion complexes obtained from cell 
lysis with different buffers. (a) TEA hypotonic buffer; (b) RIPA (left) and FA extraction 
buffer (right).  All Western blot results were from one experiment. 
 
Evaluation of Extracellular Matrix Substrate as Negative Control 
The use of a negative control ligand (e.g. apo-transferrin or poly-D-lysine) 
allows for the identification of specific fibronectin-induced adhesion 
complexes.  Cells seeded on a negative control ligand do not form integrin-
mediated cell attachments and thus the isolated proteins were considered as 
background.  We evaluated the use of poly-D-lysine (PDL) and apo-
transferrin (Apo-Tf) as negative control ligands as they have previously been 
used successfully67,131.  To this aim, the adhesion complex isolation was 
performed on Met2 and Met4 cells seeded on plates coated with fibronectin 
FAK
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(FN), PDL and Apo-Tf for 4 hours.  Adhesion complexes were stabilised in 
the presence of 3mM DTBP for 5 minutes. 
 
There was no enrichment of the adhesome proteins FAK and b1-integrin 
when PDL was used as a substrate (Figure 7).  Conversely, FAK and b1-
integrin were isolated to a similar level when FN and Apo-Tf were used 
(Figure 7).  Thus, PDL is more suitable than Apo-Tf as a negative control 
ligand for human SCC adhesion complex isolation.  Cells seeded on PDL are 
only attached by electrostatic interactions and thus does not involve the 
activation of integrin. 
 
 
Figure 7 Western blot analysis of adhesion fraction from Met2 and Met4 cells seeded 
on fibronectin (FN), apo-transferrin (Apo-Tf) and poly-D-lysine (PDL) for adhesome 
proteins (b1-integrin and FAK) and non-adhesion associated protein (Hsp90).  Cell 
lysate (right) served as a positive control.  Western blot result was from one single 
experiment. 
 
Met 2 Met 4 Met 2 Met 4 Met 2 Met 4
FN Apo-Tf PDL
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Crosslinking Concentration Evaluation and Crosslinking Time 
Evaluation 
The effects of crosslinking time and crosslinker concentration on the 
specificity of the adhesion complex isolation were assessed.  Met2 and Met4 
cells were seeded on fibronectin for 4 hours after which the cells were 
crosslinked for 30 minutes in the presence of 3mM DTBP or for 5 minutes in 
the presence of 10mM DTBP. 
 
While increasing crosslinking time to 30 minutes or increasing crosslinker 
concentration to 10mM isolated adhesion proteins FAK, phosphorylated FAK 
at Tyr397 (P-FAK), b1-integrin and vinculin for Met2 cells, these conditions 
also increased the amount of co-purifying nuclear contaminants MCM2 
(Figure 8).  Moreover, adhesion proteins were also isolated in the PDL 
control as well as co-purifying nuclear contaminants in Met4 cells (Figure 8).  
This indicated that, while these conditions isolated adhesome proteins in 
Met2 cells, neither condition was suitable for specific isolation of adhesome 
proteins in Met4 cells.  Thus, we used the initial approach of stabilising the 
adhesion complexes in the presence of 3mM DTBP for 5 minutes. 
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Figure 8 Western blot analysis of adhesome proteins isolated from Met2 and Met4 cells 
using 3mM DTBP and incubated for 30 minutes (left) or 10mM DTBP and incubated for 
5 minutes (centre). Cell lysate (right) served as a positive control.  Western blot result 
was from one experiment. 
 
Crosslinker Evaluation 
We next evaluated the use of different crosslinkers for the adhesion complex 
isolation in Met cells.  Crosslinkers dithiobis[succinimidyl propionate] (DSP) 
and 1,4-di-[3′-(2′-pyridyldithio)-propionamido] butane (DPDPB) were 
assessed for the isolation of adhesion complexes from human SCC cells 
plated on both fibronectin and poly-D-lysine.  Cell-permeable and reversible 
crosslinkers DSP and DPDPB, which crosslink primary amines and cysteine, 
residues respectively, were used in combinations at different concentrations.  
The combinations of DSP and DPDPB has been used successfully before for 
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DSP with 0.05mM DPDPB and 3mM DSP with 0.2mM DPDPB were 
assessed. 
 
When a combination of 0.5mM DSP and 0.05mM DPDPB was used to 
isolate adhesion complexes, there was a low yield of enrichment of the 
adhesome proteins P-FAK and b1-integrin from Met2 cells and Met4 cells 
except for b1-integrin in Met4 cells seeded on fibronectin (Figure 9(a)).  
However, this was non-specific since non-adhesion associated proteins 
calnexin, tubulin and MCM2 were also isolated (Figure 9(a)).  The isolation 
yield increased for Met4 cells when 3mM DSP and 0.2mM DPDPB were 
used (Figure 9(b)).  However, there was loss of specificity as indicated by the 
presence of the adhesome proteins P-FAK and b1-integrin in the PDL 
negative control (Figure 9(b)). 
 
The use of DSP and DPDPB resulted in non-specific isolation of adhesome 
proteins.  Moreover, since DMSO was used to solubilise non-water-soluble 
cross-linkers DSP and DPDPB, this can introduce organic solvent 
artefacts134.  We thus concluded that DSP and DPDPB were not suitable for 
isolation of adhesome-specific proteins.  Hence, we maintained the use of 
DTBP as crosslinker. 
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Figure 9 Western blot analysis of adhesion complexes isolated using different 
concentrations of DSP and DPDPB as crosslinkers. (a) At low crosslinker 
concentration, 0.5mM DSP and 0.05 mM DPDPB, no substantial enrichment of adhesion 
proteins phosphorylated FAK (P-FAK) and b1-integrin was observed.  However, non-
adhesion proteins MCM2 and tubulin were observed in the adhesion fraction of both 
Met2 and Met4 cells seeded on FN and PDL.  Moreover, non-adhesion associated 
protein calnexin was also isolated in Met4 seeded on FN.  (b) At high crosslinker 
concentrations, 3mM DSP and 0.2mM DPDPB, an enrichment in adhesome proteins P-
FAK and b1-integrin was observed in Met 4 cells but also an increase in the isolation of 
non-adhesome proteins MCM2 and tubulin. Western blot results were from one 
experiment. 
 
Incubation period of cells prior to isolation of adhesome 
We evaluated the maturity of adhesion complexes at different time periods to 
assess the optimum spreading time for the Met1 and Met4 cells to form 
mature focal adhesions on fibronectin.  To this aim, Met1 and Met4 cells 
were incubated for 4 hours and overnight on fibronectin and immunostained 
for P-FAK.  Actin filaments were co-stained by phalloidin.  Cells were imaged 
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After 4 hours incubation, Met1 and Met4 cells developed nascent focal 
complexes as indicated by P-FAK localised along cortical actin bundles 
(Figure 10(a)).  Met1 and Met4 cells had a high level of P-FAK at the cells’ 
apexes but no mature focal adhesions were observed (Figure 10(a)).  We 
concluded that 4 hours spreading time was not enough for either Met1 or 
Met4 cells to spread on fibronectin and form mature focal adhesions. 
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Figure 10  Confocal image of Met1 and Met4 cells after (a) 4 hours incubation on 
fibronectin-coated cover slips. Actin (red) was co-stained by phalloidin, nucleus was 
co-stained with DAPI, and P-FAK (green) was immunolabelled and (b) after overnight 
incubation on fibronectin-coated cover slips. Actin (red) was co-stained by phalloidin, 
nucleus was co-stained with DAPI, and P-FAK (green) was immunolabelled.  Images 
were representative of two independent replicates of the experiment. 
 
Conversely, when cells were incubated overnight, focal adhesions were 
found at the end of actin filaments (presumably actin stress fibres) in both 
Met1 and Met4 cells (Figure 10(b)), thereby indicating formation of more 
mature focal adhesions.  In Met1 cells, the focal adhesions were mostly 
found at the lamellipodial leading edge while in Met4, P-FAK was found at 
the end of actin stress fibres (Figure 10(b)). 
 
Taken together, we concluded that Met1 and Met4 cells should be incubated 
overnight to allow for the formation of mature focal adhesions prior to 
adhesion complex isolation.  Since cells secrete their own extracellular matrix 
when incubated for a long period of time75, we reasoned that cells incubated 
overnight on PDL would not serve as an appropriate negative control.  
Moreover, the use of a negative control is not essential when capturing 
changes in the adhesome under different conditions65,75. 
 
Optimised Adhesome Isolation Conditions 
From the evaluations discussed above, we concluded that specific isolation 
of the adhesome from Met1 and Met4 cells should be carried out using the 
following protocol.  Met1 and Met4 cells were seeded on 15-cm dish plates 
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coated with 10 µg/ml fibronectin at a density of 3x106 cells per plate and 
incubated overnight at 37°C in humidified 5% (v/v) CO2 . The cells were 
crosslinked using 3mM DTBP in the presence of DMEM/F12 for 5 minutes at 
37°C, after which the crosslinker was quenched with 20 mM Tris.HCl for 2 
minutes at room temperature.  Cells were washed with an additional 200mM 
Tris-HCl prior to lysis with ice-cold 5ml FA extraction buffer for 30 minutes. 
Cell bodies were removed by hydrodynamic force using a Waterpik device 
with ice-cold PBS.  These conditions enriched for adhesion-associated 
proteins with minimal co-purifying contaminants (Figure 11). 
 
Figure 11  Western blot of optimised adhesion complex  isolation for Met1 and Met4 
cells.  Focal adhesion proteins Talin, P-FAK, FAK and aV-integrin (ItgaV) were isolated 
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cytoplasmic protein GAPDH and nuclear proteins Histone H3 (HisH3) were not 
isolated.  Western blot result was representative of two independent experimental 
replicates. 
Adhesome Proteomics Dataset 
For proteomic analysis of the human SCC adhesome, adhesion complexes 
were isolated in three biological replicates for each cell line, Met1 and Met4.  
The isolated adhesion complexes were analysed by LC-MS/MS, producing 
an adhesome proteomics dataset consisting of 1941 proteins identified by at 
least two peptides.  The adhesome proteins were quantified by a label-free 
quantification (LFQ) approach whereby the LFQ of proteins are determined 
from the quantification of the MS1 spectra of the peptides from which the 
proteins were inferred to have been derived.  MS1 spectra are the mass 
spectra derived from all the peptides eluted from the liquid-chromatography 
column at any given time into the first stage of the mass-spectrometer, 
yielding the m/z and intensity of the peptides78. 
 
All replicates had a minimal variation in total LFQ intensity (missing values 
ignored) between the replicates (coefficient of variation = 3.16%, Figure 
12(a)).  The number of missing values were approximately consistent 
between replicates with the exception of two biological replicates of Met1 
(Rep 1 and Rep 3), both of which had more missing values than any other 
replicates (Figure 12(b)).  Nevertheless, multidimensional scaling (MDS) of 
the Euclidean distance between the replicates shows that Met1 and Met4 
triplicates clustered together as separate condition groups (i.e. the cluster of 
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red spots (Met1) is distinct from the cluster of green spots (Met4) (Figure 




Figure 12  Bar chart of (a) total LFQ intensity of identified proteins and (b) total number 
of missing values in each replicate of the adhesome mass-spectrometry proteomics 
dataset.  (c) LFQ intensity MDS plot applied to each replicate of the adhesome mass-











































































(c) LFQ Intensity MDS plot
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Adhesome Proteomics Dataset Pre-processing 
LC-MS/MS experiments can generate high-dimensional data: the abundance 
level of thousands of proteins measured simultaneously across many 
biological samples.  Unfortunately, the proteomics data generated in such 
experiments is often affected by extraneous variation and systematic error, 
both of which are caused by technical factors135.  Both extraneous variation 
and systematic error can introduce bias, thereby confounding the analysis of 
differential proteins abundance level due to biological change.  To reduce 
extraneous variations and correct for systematic error, normalisation of the 
proteomics dataset is required.  Karpievitch et al80 suggested that 
normalisation of proteomics dataset be performed first, followed by 
imputation of missing values.  Hence, we evaluated different normalisation 
approaches on the adhesome proteomics first, followed by evaluation of 
imputation methods on the normalised adhesome proteomics dataset. 
 
Different normalisation methods —total intensity normalisation (TI), median 
intensity normalisation (MedI), average intensity normalisation (AI), quantile 
normalisation, variance stabilisation normalisation (VSN), robust linear 
regression normalisation (RLR) and cyclic loess normalisation (Loess) — 
were assessed for their ability to reduce intragroup variation between 
biological replicates of the adhesome proteomics dataset.  These 
normalisation methods were applied globally (denoted by G), i.e. the whole 
dataset was normalised as one.  VSN, RLR and Loess were also applied 
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locally (denoted by R), whereby the condition groups (adhesomes derived 
from Met1 and Met4 cells) were normalised separately.  Prior to 
normalisation, the LFQ intensities were log2 transformed to approximate the 
LFQ intensities into a normal distribution.  Intragroup variation was measured 
using pooled coefficient of variation (PCV), pooled median absolute deviation 
(PMAD) and pooled estimate of variance (PEV).  PCV, PMAD and PEV 
measure the variation in log2-transformed LFQ intensities within the protein 
population across the Met1 and Met4 condition groups.  Surprisingly, 
quantile, TI, AI and MedI normalisation increased the intragroup variation in 
the replicates compared to log2 transformation alone (Figure 13).  Therefore, 
these approaches were unsuitable for the normalisation of the isolated 
adhesome proteomics dataset.  Loess, RLR and VSN applied both locally 
and globally performed better at reducing average PCV, PMAD and PEV 
than the rest of the normalisation methods (Figure 13).  The ranges of PCV, 
PMAD and PEV were also reduced when Loess, RLR and VSN were applied 
globally compared to when applied locally.  Globally applied RLR (RLR-G) 
normalisation produced the smallest range of PCV, PMAD and PEV (Figure 
13).  Thus, normalisation by RLR-G performed the best in reducing the 
intragroup variation in the isolated adhesome proteomics dataset and was 
used for the normalisation of this dataset. 
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Figure 13 Comparison of the effects of normalisation methods on the intragroup 
variation measured by (a) PCV, (b) PMAD and (c) PEV.  Loess, RLR and VSN applied 
both globally (-G) and locally (-R) produced the lowest average PCV, PMAD and PEV.  
RLR-G produced the smallest range of PCV, PMAD and PEV. 
MA plots visualise the differences between the protein abundance 
measurements, by transforming the data onto the difference between 
biological replicates of (M) and average of (A) log2-transformed LFQ values 
for each protein.  MA plots were used to explore the bias in the different 
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point cloud scattered along the x-axis (M=0)110 with the loess smoother line 
(non-parametric line of best fit) lying along the x-axis.  Identical biological 
replicates are not essential for this property to be observed.  Rather, the 
samples only have to be biologically related such that most proteins are 
assumed not to be differentially abundant.  Since Met1 and Met4 cell lines 
are both squamous cell carcinoma (SCC) cells derived from the same 
patient, we hold this assumption to be true.  Figure 14 shows an MA plot 
whereby LFQ intensities of proteins quantified in Met1 Replicate 1 are set as 
the reference against which the LFQ intensities of proteins quantified in the 
other biological replicates are subtracted, and A is the average LFQ intensity 
for each protein among all biological replicates.  Prior to normalisation, the 
loess smoothers noticeably deviated from the x-axis at the dense region of 
the point cloud (Figure 14(a)).  Moreover, the loess smoothers were ‘banana’ 
shaped (Figure 14(a)), as has been previously described79,109,136.  This 
suggests that the biological replicates were biased prior to normalisation, i.e. 
most proteins were inherently differentially abundant as a result of 
extraneous variations and systematic error and not due to biological change 
(primary vs metastatic cells).  Normalisation by RLR-G reduced the deviation 
at the dense region of the point cloud though it did not correct for the 
deviation at the higher average LFQ intensity values and lower average LFQ 
intensities.  The loess smoothers appear to be modified at the extremes by 
only a few data points.  Thus, it is possible that the observed deviation at the 
high and low abundance proteins is due to biological change between 
adhesomes derived from Met1 and Met4 cells. 
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Figure 14 MA plot (a) before and (b) after RLR-G normalisation.  The scatter points 
represent the difference versus the average protein intensities.  The solid lines are 
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loess smoothers.  Different sets of replicates for Met1 and Met4 are represented by 
different colours. 
Imputation 
Following RLR-G normalisation, the patient-derived SCC adhesome dataset 
was filtered for proteins which contained at least two log2-transformed LFQ 
intensity values in either condition group.  This resulted in 1727 adhesome 
proteins which have been identified in at least two biological replicates in the 
adhesome dataset.  The missing values were imputed using MI and LSA.   
 
LSA is a function of the LSImpute package87.  LSA is a local similarity-based 
imputation approach86 whereby it is assumed that proteins which are co-
regulated will have highly correlated expression profiles.  The missing values 
are estimated by multiple regressions between the proteins with missing 
values and their respective most correlated proteins as well as multiple 
regressions between the biological replicates. 
 
The MI method used here involved a first-pass single value imputation (SVI) 
dependent on satisfaction of an assumption criterion followed by a second-
pass imputation by predictive mean matching (PMM).  PMM has the 
advantage of being a non-parametric imputation method; hence, the data 
need not follow a normal distribution at this stage.  The first-pass imputation 
criterion is as follows: if and only if a protein had missing LFQ intensity 
values in all biological replicates in the same condition group, we assumed it 
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was missing-not-at-random (MNAR) and therefore the missing values in each 
replicate were imputed by the minimum LFQ intensity value (of all proteins) in 
that particular replicate. 
 
Prior to imputation, 16.5% of the entire dataset were missing values.  After 
the first-pass imputation, 8.7% of the entire dataset were missing values.  
These remaining missing values were treated as not MNAR and therefore 
imputed by PMM.  Suppose a dataset 𝑌, consisting of both observed values 
(𝑌ABC) and missing values (𝑌D%C).  Using Bayesian methods, a posterior 
predictive distribution for 𝑌D%C using 𝑌ABC is generated and imputations are 
drawn from this posterior distribution.  Using all imputed values and observed 
values, another posterior predictive distribution for 𝑌D%C is generated and 
imputation values are again drawn from this second pass posterior predictive 
distribution.  This process is repeated multiple times, refining the posterior 
predictive distribution for 𝑌D%C until the distribution stabilises. At this stage, the 
predicted values for the observed values in the imputed dataset will be close 
to the initial observed value (𝑌ABC) of the corresponding dataset with missing 
values.  Because PMM uses a Bayesian approach to ‘predict’ the missing 
values, it is useful to test whether the imputed values by PMM follow the 
same distribution as the original dataset.  Figure 15 shows scatter plots of 
Met1 Replicate 1 against all the other replicates.  The imputed values 
(magenta) fell within the same point spread as the original observed values 
(blue), indicating the imputed values were indeed ‘plausible’ values.  Most of 
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the imputed values were low LFQ intensities,  which is in agreement with the 
inverse correlation between missing values and protein abundance137. 
 
Figure 15 Scatter plot of log2 transformed LFQ intensities of Met1 Replicate 1 versus 
log2 transformed LFQ intensities for all other replicates.  The original observed values 
are coloured blue, while the imputed values are in magenta. 
 
Assessing the accuracy of the imputed values is not feasible in this 
experimental setting as the true LFQ intensity values are unknown.  
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However, the aim is to obtain an accurate estimate of the log fold changes 
and not an accurate estimate of the LFQ intensities.  Thus, the log fold 
change (logFC) of LFQ intensity in the imputed datasets was compared to 
the relative protein abundance (RPA) obtained from western blot validation of 
the isolated adhesome.  Western blotting is a low-throughput method and 
thus the relative protein abundance of only a few proteins could be assessed.  
Moreover, only two western blot replicates were produced and hence the 
RPA estimates were only preliminary.  Nevertheless, the RPA and logFC of 
three proteins namely Mena, aV-integrin and FAK, were compared.  The 
accuracy of the fold change was assessed by the root mean square deviation 
(RMSD) between the RPA and the logFC for those three proteins.  The lower 
the RMSD, the more accurate the estimate is to the true value.  Mena and 
aV-integrin were both imputed by SVI as both had replicates missing 
completely in the isolated adhesome from Met1 and Met4 cells, respectively.  
FAK was imputed by PMM.  MI outperformed LSA at accurately estimating 
differential protein abundance with RMSD of 7.33 for MI compared to RMSD 
of 31.29 for LSA.  Hence, the adhesome proteomics dataset was imputed 
using MI. 
 
We used a relative log expression (RLE) plot to check for bias138 in the 
isolated adhesome proteomics biological replicates before and after 
normalisation and imputation.  The RLE plot is a powerful visualisation tool to 
check for sample heterogeneity by computing the deviations between, in this 
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case here, the log2-transformed LFQ intensity for each protein in each 
biological replicate and the median log2-transformed LFQ intensity for each 
protein across the replicates.  The median log2-transformed LFQ intensity is 
used to protect against outliers.  The computed deviations of all proteins are 
represented by a boxplot for each biological replicate. 
 
Prior to normalisation and imputation, the biological replicates were biased 
as indicated by the varying positions of the boxplots (Figure 16(a)).  This 
agrees with the earlier MA plot analysis indicating a similar conclusion 
(Figure 14(a)).  Conversely, upon RLR-G normalisation, the mean deviations 
of the biological replicates centred along 0 in the RLE plot (Figure 16(b)), 
indicating RLR-G reduced the inherent bias present in the biological 
replicates prior to normalisation.  Moreover, imputation by MI did not affect 
the distribution of the mean deviations, indicating that no bias was introduced 
by MI imputation (Figure 16(c)).  We are therefore confident that the 
normalised and imputed adhesome proteomics dataset could be used for 
further downstream analysis. 
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Figure 16 RLE plot of the log2 transformed LFQ of the isolated adhesome for each 
biological replicate (a) prior to normalisation (b) after RLR-G normalisation and (c) 
after RLR-G followed by MI imputation. 
 
<Discussion 
In order to study the adhesome in a cancer progression setting, we isolated 
adhesion complexes from malignant cutaneous SCC cells derived from the 
primary site (Met1) and secondary metastatic site (Met4) of the same patient.  
The adesome isolation methodology was optimised for Met1 and Met4 cells 
to enrich for adhesome proteins — such as FAK, phosphorylated FAK, talin 
and aV-integrin — whereas co-purifying contaminants, such as nuclear 
protein Histone H3, mitochondrial protein complex IV and cytosolic protein 
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carried out once.  Three biological replicates for each Met1 and Met4 
adhesome fraction were analysed by LC-MS/MS to produce an adhesome 
proteomics dataset. 
 
Data pre-processing was performed on the adhesome dataset with the aim of 
reducing bias and variability, as well as improving accuracy for protein 
abundance analysis downstream in the analysis pipeline.  Different 
normalisation methods were evaluated for best reducing intragroup variability 
and bias.  RLR-G showed the best performance at reducing intragroup 
variability as measured by PCV, PMAD and PEV.  Moreover, both the MA 
plot and RLE plot showed that RLR-G normalisation reduced bias in the LFQ 
intensities of the biological replicates. 
 
A multiple imputation method (MI) was used which accounted for different 
types of missingness.  Here, performance of the imputation method was 
assessed for accuracy in estimating the log fold change rather than 
estimating the LFQ intensity.  MI outperformed LSA in accurately (as 
assessed by RMSD) estimating the fold change.  This agrees with the finding 
that multiple imputation strategies are known to produce the best results83.  
Moreover, imputation by MI did not introduce bias in the LFQ intensities as 
shown by RLE plot analysis. 
 
Understanding the adhesome network in primary and metastatic cutaneous 
squamous cell carcinoma 
Adhesome Isolation Optimisation & Proteomics Data Pre-processing 91 
Both MI and LSA were carried out at the protein level.  It has been reported 
that MCAR imputation performs best at the peptide level, before peptide 
aggregation into proteins, while MNAR imputation performs best at the 
protein level83.  However, this has not been implemented here since the 
peptide aggregation software used (MaxQuant) did not, at the time of 
analysis, offer imputation at the peptide level.  Nevertheless, the evaluation 
here provides us with confidence that the normalised and imputed adhesome 
proteomics dataset can be used for differential protein abundance analysis in 
the context of a protein-protein interaction network (chapter 4). 
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<Introduction 
In the chapter 3, adhesion complexes isolated from patient-derived 
squamous cell carcinoma (SCC) cells were analysed by LC-MS/MS and the 
resulting proteomic dataset normalised and missing data imputed.  Using 
differential protein abundance analysis alone treats the proteomics data as 
sets and ignores information such as the interaction between the individual 
proteins.  The adhesome proteins interact with one another to form an 
adhesome network61.  Therefore, we analysed the dataset for differential 
protein abundance using a network approach.  .   
 
It is becoming evident that disease-associated proteins (such as those 
differentially regulated between disease phenotypes) interact with each other 
to form modules in the interactome map88,89.  Those modules (disease-
specific functional modules) are postulated to drive disease phenotypes88.  In 
a similar way, differentially abundant adhesome proteins between the 
patient-derived Met1 (primary) and Met4 (metastatic) SCC cells may interact 
with one another in the adhesome network to form a module (or modules) 
responsible for cancer progression. 
 
An important feature of protein-protein interaction networks is the presence 
of highly connected proteins (in other words, proteins which interacted with 
multiple proteins) called hubs.  During cancer progression, some hubs rewire 
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within the signalling network to drive phenotypic alterations but still maintain 
the robustness of the signalling network100.  It is therefore important to study 
such network feature as hubs may be functional targets for inhibiting 
metastasis. 
 
Han et al.98 reported two classes of hubs based on the average Pearson 
correlation coefficient (avPCC) of expression levels between the hub and its 
interacting partners.  ‘Party’ hubs were highly coexpressed with their 
neighbours (high avPCC) and thus coordinate proteins within the same 
community (intra-module hub)99.  ‘Date’ hubs, which had relatively low 
coexpression (low avPCC), were considered as inter-module hubs.  The 
latter interact with different binding partners under different conditions and 
may thus perform different functions99-101.  Hence, the identification of ‘date’ 
hubs in the adhesome network could identify a ‘switch’ protein whose 
aberrant interaction with different binding partners may drive a metastatic 
phenotype. 
 
Guimera and Amaral94,103 classified hubs in terms of their structural roles 
within their respective communities.  Communities are clusters of interacting 
nodes which are highly interconnected to one another.  In protein-protein 
interaction networks, proteins within a community are postulated to 
participate in the same molecular processes104.  Nodes with within-
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community degree (z) ³ 2.5 are considered as hubs.  Those hubs can be 
further categorised into provincial hubs, connector hubs and kinless hubs 
according to their participation coefficient (see Methods). 
 
The classification of hubs such as date and party hubs98, connector, kinless, 
and provincial hubs94,103, inter-module and intra-module hubs100,101 is not 
mutually exclusive.  Indeed, connector and kinless hubs have been reported 
to behave as date hub, and provincial hubs have been reported to behave as 
party hubs, though the similarity between provincial and party hubs was 
modest99. 
 
The aim here is to understand how the adhesome changes during cancer 
progression and subsequently identify adhesome hubs which may be crucial 
to cancer progression.  Moreover, we wish to identify kinless and connector 
hubs (inter-module hubs, date hubs), as these hubs have been reported to 
integrate different molecular processes and perform different functions under 
different conditions100 and hence may be sites of rewiring in the adhesome 
network driving metastasis. 
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The first step in the network analysis is to integrate changes in adhesome 
proteins abundance between Met1 and Met4 cells into the network system 
under study.  Here, the network under study is the adhesome SCCs network, 
which consists of patient-derived SCC adhesome proteins isolated from Met1 
and Met4 cells and their putative protein-protein interactions obtained from 
BioGrid139 — a curated repository database for protein-protein interactions.  
Once the changes in adhesome proteins abundance are integrated in the 
adhesome SCCs network, we identify a connected module within the network 
that contains statistically significant differentially abundant adhesome 
proteins between the Met1 and Met4 as these proteins may interact with one 
another to drive a metastatic phenotype.  Such a connected module is called 
the active module.  To this aim, a comprehensive R package for finding 
active modules, BioNet115,116, was used. 
 
The patient-derived adhesome dataset consists of 1727 proteins identified by 
LC-MS/MS and isolated from at least two biological replicates of either Met1 
or Met4 cells.  The p-values of the log2-transformed fold changes between 
the Met1 and Met4 adhesome were converted into scores using a signal-
noise decomposition scoring function.  The signal component of the scoring 
function is modelled by a beta distribution function B(a,1), where a is the 
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shape parameter of the signal component.  The noise component is 
modelled by a uniform beta distribution B(1,1).  Taken together, the signal 
and noise component are fitted to a beta uniform mixture model.  The scoring 
function, 𝑆(𝑥), was thus defined as the log-likelihood ratio of the beta 
distribution to the uniform distribution: 
𝑆(𝑥) = 𝑙𝑜𝑔 6
𝐵(𝑎, 1)(𝑥)
𝐵(1,1)(𝑥); = log
(𝑎) + (𝑎 − 1)log	(𝑥) 
where 𝑥 is the empirical p-value and 𝑎 is the shape parameter of the signal 
component. 
When adjusted for false discovery rate, the scoring function can be simplified 
to:  
𝑆(𝑥) = (𝑎 − 1)(log(𝑥) − log	(𝜏(𝐹𝐷𝑅)) 
 where 𝑥 is the p-value, 𝑎 is the shape parameter and 𝜏(𝐹𝐷𝑅) is the false 
discovery rate threshold. 
 
The p-values determined from the adhesome dataset using Student’s t-test 
were fitted to a beta uniform mixture model (Figure 17(a)) and the shape 
parameter of the signal component, 𝑎, was determined using the L-BFGS-B 
algorithm (called for by the BioNet package) which resulted in 𝑎 = 0.3275.  
The Q-Q plot shows that the distribution of the observed p-values from the 
adhesome dataset does follow the fitted beta distribution (Figure 17(b)).  The 
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score for each node was thus computed using an FDR of 0.05 and 𝑎 =
0.3275. 
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Figure 17 (a) Histogram of the p-values from the adhesome dataset fits the beta uniform 
mixture model.  The signal component is denoted by the red line.  The noise component 
is denoted by the blue line.  The parameter for the mixture model is 𝒂 = 0.3275.  (b) The 
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observed p-values form the adhesome dataset fits the beta distribution as shown by 
the Q-Q plot. 
Of the 1727 isolated adhesome protein, 1708 proteins were mapped onto the 
BioGrid physical protein-protein interaction network.  The 19 unmapped 
isolated adhesome proteins were missing in the BioGrid physical protein-
protein interaction network139 at the time of the analysis.  Of the 1708 
mapped proteins in the BioGrid protein-protein interaction network, 1668 
proteins formed a connected network.  This connected network is referred to 
as the adhesome SCCs network.  Around 60% of the proteins in the 
adhesome SCCs network also occur in the meta-adhesome (Figure 18).  The 
latter is a database of fibronectin-induced adhesome proteins identified by 
mass spectrometry68 (Figure 18). 
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Figure 18 Venn diagram illustrating the number of proteins in the adhesome SCCs 
which also occur in the meta-adhesome database. 
 
The scores derived from the beta-uniform mixture model were mapped onto 
the adhesome SCCs network.  The active module is the maximal-scoring 
connected subnetwork116,140,141.  However, it has been mathematically proved 
that extracting the best-scoring connected subnetwork is an NP-hard 
problem140 and thus only suboptimal solutions are obtained using heuristic 
approaches141,142.  The advantage of using BioNet is that the problem of 
finding the maximal-scoring connected subnetwork is converted into a prize-
collecting Steiner tree problem (PCST).  The latter is then solved using 
integer linear programming, which produces a subnetwork considered as the 
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optimal best-scoring connected subnetwork.  Using this approach on the 
scored adhesome SCCs network, an active module consisting of 720 
proteins was obtained (Figure 19).  The active module represents the 
statistically significant differentially abundant adhesome proteins between the 
Met1 and Met4 and how they are connected to one another (Figure 19).  The 
active module shares around 59% of proteins with the meta-adhesome 
dataset (Figure 20). 
 
Figure 19 The active module identified by the scores based on the p-values obtained 
using Student’s t-test and an FDR of 0.05.  Blue nodes represent adhesome proteins 
which have at least two-fold upregulation in Met4 (metastatic).  Red nodes represent 
adhesome proteins which have at least two-fold upregulation in Met1 (primary).  Grey 
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nodes represent adhesome proteins which are not differentially regulated but are 
essential for the connectivity between the differentially regulated proteins. 
 
 
Figure 20 Venn diagram illustrating the number of common adhesome proteins in the 
active module to that of the meta-adhesome dataset. 
 
Cartography of active module 
To understand the organisation of the active module and identify the kinless 
and connector hubs, it is essential to obtain a cartographic picture94,103 of the 
active module.  To this aim, the active module was partitioned into 
community structures and the within-module degree and participation 
coefficient of each node were computed.  Community structure is a property 
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common to many networks, including biological networks143, and gives a 
mesoscale view of a biological system.  Nodes within the same community in 
a protein-protein interaction network have been postulated to participate in 
the same molecular processes.  Indeed, knocking out the nodes within the 
same community resulted in the same phenotype in yeast, suggesting that 
nodes within the same community participate in the same molecular 
processes104.  A plethora of community structure algorithms95,144 have been 
developed, each using different definitions of a community.  The community 
structure algorithms used are the Louvain, spectral optimisation of 
modularity, Infomap and Constant Potts model (CPM).  The Louvain 
method117 and spectral optimisation of modularity approach120,121 both define 
communities as clusters within the network with high links density compared 
to the rest of the network.  Infomap considers communities as regions within 
the network where information flows quickly and easily145.  CPM as applied 
by Traag et al.123 is a resolution-limit-free approach that uses a tuneable 
resolution parameter.  To find the best resolution parameter for CPM, a 
quality function called Surprise (S)125 — a measure of how unlikely a given 
community structure is found in a random network — was used.  Thus, the 
best resolution parameter for CPM will produce maximum Surprise (i.e. the 
community structure is most unlikely to occur in a random network).  These 
four community detection algorithms were used to obtain a consensus role of 
the individual nodes with respect to the community structure. 
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The extracted active module is static and does not reflect the dynamics of 
protein-protein interactions under different biological conditions98,146.  Thus, 
to capture the dynamics of the protein-protein interactions, the edges were 
weighted using the Pearson rank correlation coefficient which was previously 
found to be the most effective measure of functional links147.  The Pearson 
rank correlation coefficient was increased by a value of one integer so that 
only positive values were obtained.  Thus, edges between positively 
correlated interacting proteins have higher weights than those of negatively 
correlated interacting proteins. 
 
The Louvain method117 partitioned the active module into 12 communities 
(Figure 24(a)) resulting in a Girvan-Newman modularity value of 0.475.  To 
test the significance of the partition (i.e. that the partition is not due to 
randomness), 1000 random networks with identical degree distribution and 
edge weights (also called a configuration model) as the active module148 
were generated and the modularity computed.  This resulted in modularity of 
0.255 ± 0.003.  Hence, the active module has a significant modularity (z-test, 
p-value <0.0001, z-value 2435.0) suggesting that the community structure 
obtained is a relevant feature of the network and not a by-product of 
randomness and the degree sequence. 
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The Girvan-Newman modularity obtained by spectral optimisation was 0.553, 
with 57 communities detected (Figure 24(b)).  Some of the communities were 
single nodes.  Spectral optimisation seemed to result in a better partition 
(higher modularity value) compared to the Louvain method; however, the 
significance of the partition was not tested. 
 
Modularity-based methods suffer from resolution limit149, whereby the size of 
the communities depends on the size of the network.  CPM is a resolution-
limit-free approach, which uses a tuneable resolution parameter g in the 
range of 0 to 1.  Hence, the size of the communities depends on g.  The 
active module was partitioned using a resolution parameter, g, of 0.0479, 
which produced maximum S (Figure 21).  The latter parameter measures 
how unlikely a given community structure is found in a random network.  
Using maximum S has been found to give accurate community structures125.  
This approach identified 177 communities, many of which were single nodes. 
 
Infomap finds community structures within a network by tracking the 
information flow through the network145,150.  Infomap partitioned the active 
module into 50 communities, some of which are single nodes.  The 
significance of the partition was not tested. 
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Figure 21 A resolution profile of the active module.  The resolution parameter was 
scanned in the range of 0 to 1 for which Surprise is maximum for the active module.  
This resulted in g  = 0.0479.  The resolution axis (x-axis) is in log scale. 
 
The observations from the analysed community structures were twofold: 
1) In general, proteins which are upregulated in the Met1 (primary) 
adhesome network tend to be within the same community, while 
proteins which are upregulated in the Met4 (metastatic) adhesome 
network tend to be in separate communities (red nodes cluster with 
red nodes, blue nodes cluster with blue nodes, Figure 24).  Co-
regulated proteins within the same community have been postulated 
to participate in the same molecular pathway.  Thus, this observation 
!
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is indicative of differentially regulated molecular processes at the 
adhesome level in the SCC cells.  
2) Different community detection algorithms produced diverse 
communities of varying sizes.  This makes it hard to determine the 
true community structure.  We could not find a consensus community 
in the SCC adhesome network, which hampered the subsequent 
identification of the differentially regulated molecular processes by 
gene ontology enrichment analysis. 
 
Once the community structures are defined in a network, the nodes can be 
categorised in the z-P parameter space (Figure 22)  In the z-P parameter 
space, the nodes are classified by virtue of the number of binding partners 
within their communities and the number of binding partners outside their 
communities.  It has been postulated that nodes with similar role within the 
community would share the same region in the z-P parameter space94,103.  
 
Of interest is the identification of kinless (R7 in Figure 22) and connector (R6 
in Figure 22) hubs.  These hubs interact with nodes in other communities.  
Connector hubs have many links to most other communities, while kinless 
hubs have links homogeneously distributed among all other communities in 
the network.  In protein-protein interaction networks, connector and kinless 
hub proteins link different molecular processes and perform different 
functions under different conditions99-101.  Therefore, the kinless and 
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connector hubs in the adhesome SCCs network are proteins that may 
‘switch’ interactions to proteins regulating different molecular processes, and 
thus perform different functions under primary and metastatic conditions.  
The connector and kinless hubs are labelled by their gene name in the z-P 
parameter space (Figure 23) and in the active module with respect to their 
communities (Figure 24). 
 
Figure 22  The z-P parameter space divided into regions defining the roles of nodes 
with respect to the community structures.  Non-hubs are categorised into 
ultraperipheral (R1), peripheral (R2), connector (R3) and kinless (R4) nodes.  Hubs are 
categorised into provincial (R5), connector (R6) and kinless (R7) hubs. 
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Figure 23.  Location of nodes within the zP parameter space when the active module is 
partitioned into communities by (a) Louvain method, (b) modularity spectral 
optimisation, (c) Constant Potts model with Surprise maximisation and, (d) Infomap.  
The hubs are denoted by their gene name. 
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Figure 24 Active module partitioned by (a) Louvain method, (b) modularity spectral 
optimisation approach, (c) Constant Potts model with Surprise maximisation approach 
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lines.  Kinless and connector hubs are denoted by their gene name.  Blue nodes 
represent adhesome proteins which have at least two-fold upregulation in Met4 
(metastatic).  Red nodes represent adhesome proteins which have at least two-fold 
upregulation in Met1 (primary).  Grey nodes represent adhesome proteins which are 
not differentially regulated but are essential for the connectivity between the 
differentially regulated proteins. 
 
Date and party hubs dichotomy 
As mentioned above, Han et al.98 reported two classes of hubs based on the 
average expression levels between the hub and its interacting partners.  
Party hubs were highly co-expressed with their neighbours and thus 
coordinate proteins within the same community, whereas date hubs have low 
co-expression with their interacting partners and may therefore interact with 
different binding partners to perform different functions under different 
conditions and at different locations99-101. 
 
To test whether the connector and kinless hubs in the active module are date 
hubs, the average Pearson correlation coefficient (avPCC) of the protein 
abundance between the hubs and their interacting partners were computed.  
The avPCC followed a multimodal distribution with three distinct population of 
hubs with increasing avPCC values (Figure 25).  Nevertheless, the 
dichotomy of party and date hubs was maintained here with an avPCC of 0.5 
used as the boundary (Figure 25, black arrow) to distinguish between date 
hubs and party hubs.  A high proportion (85.7%) of kinless and connector 
hubs had low avPCC and hence were assigned as date hubs.  A low 
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proportion (14.3%) of kinless and connector hubs had high avPCC and 
hence were assigned as party hubs. 
 
Figure 25 Distribution density of the avPCC between the kinless and connector hubs 
and their interacting partners in the active module.  avPCC shows a multimodal 
distribution with avPCC = 0.5 (black arrow) used to separate the date (blue arrow) and 
party (red arrow) hubs. 
 
The classification of connector and kinless hubs relies on the boundaries of 
the z-P parameters.  Though these boundaries are based on mathematical 
arguments and validated empirically using real networks 94,103, it is plausible 
that these boundaries may not apply to the active module above.  Hence, in 
order to validate those hubs, another class of method, namely, a direct 
method approach, was used to determine the importance of the nodes in the 
adhesome SCCs network.  Here, the importance of a node not only depends 
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on its structural role within the network but also by its ‘influence’ or ‘support’ 
from its neighbours.  One analogy is the citation of scientific papers.  
Influential scientific articles would be cited numerous times or given ‘support’ 
by other articles.  However, an article with few citations may also be 
influential if it is cited by other influential articles.  Using the same principles, 
we used the PageRank algorithm151 to rank the importance of each protein in 
the active module.  PageRank is the algorithm used by the Google search 
engine to determine the relevance of webpages and has been applied 
elsewhere to rank proteins151.  PageRank determines the importance of a 
node not only by the quantity of links (degree centrality) but also by the 
quality of the neighbouring nodes126.  In protein-protein interaction networks, 
influential nodes linking highly interconnected proteins will be highly scored. 
 
As opposed to using positive weighted edges for the community detection 
algorithms in the z-P analysis, PageRank is compatible with negative 
weighted links.  To rank the adhesome proteins by their influence and 
connectivity, the PageRank score was plotted against the degree 
connectivity.  This approach is similar to that used by Reuter et al.152 
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Figure 26 Influence and connectivity plot of the 720 adhesome proteins in the active 
module.  
 
Fibronectin (FN1), an extracellular matrix protein, was ranked top — as 
presented in Figure 26 — out of the 720 nodes in the active module.  
Moreover, fibronectin was also found to be a kinless hub in the community-
assisted approaches (Figure 23(a), (b), (d) & Figure 24(a), (b), (d)).  Being a 
kinless hub indicates that fibronectin has links homogeneously distributed to 
other communities in the active module, thus suggesting that fibronectin may 
induce different molecular processes in Met1 and Met4 cells.  Being highly 
scored by the PageRank-degree analysis confirms that fibronectin links 
highly interconnected protein clusters with other highly interconnected protein 
clusters.  This is expected since Met1 and Met4 cells were seeded on 
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fibronectin, an extracellular matrix protein, to induce the formation of the 
adhesome.  Taken altogether, it is plausible that fibronectin may induce 
different molecular pathways during cancer progression.  This hypothesis 
has yet to be experimentally validated. 
 
Consensus vital hubs. 
Approximately half (54%) of the kinless and connector hubs determined in 
the z-P analysis were also highly ranked by PageRank-degree as shown in 
Figure 26.  The consensus adhesome SCCs hubs (CASH) are hubs which 
have been determined by both the z-P analysis (community-assisted 
approach) and PageRank-degree analysis (direct approach) and which 
occurred in at least three datasets in the meta-adhesome database.  These 
criteria resulted in the identification of eight CASH hubs, namely exportin-1 
(XPO1), replication protein A1 (RPA1), fibronectin (FN1), ELAV-like protein 1 
(ELAVL1), heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), Ewing 
sarcoma breakpoint region 1 protein (EWSR1), myosin-9 (MYH9) and RNA-
binding protein fused in sarcoma (FUS).  Figure 27 shows the frequency by 
which the CASH proteins were identified by the different community detection 
algorithms.  All CASH behaved as date hubs, having low avPCC (avPCC < 
0.5) with their neighbouring proteins. 
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Figure 27 Bar chart showing the number of times the consensus adhesome SCCs hubs 
(CASH, x-axis) were defined as hubs using the community-assisted approach.  XPO1 
and RPA1 were the most frequently detected as hubs by the different community 
detection algorithms. 
 
RPA1 and XPO1 were the most frequently identified hubs by the community 
detections algorithms (Figure 27).  Replication protein A1 (RPA1) binds to 
single strand DNA to mediate DNA repair, DNA replication and homologous 
recombination153,154.  Exportin-1 (XPO1 also known as CRM1) binds to 
protein cargoes with a nuclear export sequence (NES) and mediates their 
nuclear export from the nucleus to the cytoplasm155. 
 
Both RPA1 (avPCC = 0.240) and XPO1 (avPCC = 0.034) behave as date 
hubs which suggests that XPO1 and RPA1 may bind to different proteins in 
primary and metastatic cells (Met1 and Met4 respectively).  RPA1 and XPO1 
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and in Met4 as well as with adheseome proteins whose abundance did not 
change.  It has been reported that interactors of date hubs tend to be 
localised in multiple subcellular compartments within the cell98.  Since both 
XPO1 and RPA1 behave as date hubs, we expect interactors of XPO1 
(Figure 28(a)) and RPA1 (Figure 28(b)) to be in multiple subcellular 
compartments within the cell.  The calculation of the localization entropy98 of 
the interactors is required to test this hypothesis.  This will be carried out in 
future work. 
 
The primary function of exportin-1 is to mediate the nuclear export of proteins 
to the cytoplasm.  Interestingly, interactors of XPO1 in the active module 
consist of canonical focal adhesion components, such as paxillin (PXN), 
integrin-linked kinase (ILK), mammalian enabled homologue (Mena, gene 
name: ENAH) and zyxin-related protein 1 (TRIP6).  This suggests that those 
proteins may shuttle to the nucleus and indeed paxillin, ILK and TRIP6 were 
previously reported to shuttle to the nucleus156-162, although this not been 
reported for ENAH. 
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Figure 28 Interactors of (a) XPO1 and (b) RPA1 in the active module filtered for meta-
adhesome proteins.  The size of the node represents the occurrence of the protein in 
datasets of the meta-adhesome.  Red nodes represent adhesome proteins that have at 
least two-fold upregulation in Met1 (primary).  Blue nodes represent adhesome proteins 
that have at least two-fold upregulation in Met4 (metastatic). Grey nodes represent 
adhesome proteins that are not differentially regulated. 
 
<Discussion 
In chapter 3, we previously isolated adhesome proteins from primary (Met1) 
and metastatic (Met4) patient-derived cutaneous SCC cells.  Three biological 
replicates of the isolated adhesome for Met1 and Met4 were analysed by LC-
MS/MS.  This resulted in the identification of 1727 proteins which was 
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adhesome changes during cancer progression and subsequently identify 
adhesome proteins that may be crucial to cancer progression. 
 
The changes in the adhesome between primary (Met1) and metastatic 
(Met4) SCC cells were captured by the active module, which is a network of 
differentially regulated adhesome proteins and how they are connected to 
one another.  Interestingly, the active module has a community structure 
(modular structure) with coregulated adhesome proteins clustering among 
themselves.  Indeed, four separate community detection algorithms (Louvain, 
spectral modularity optimisation, CPM with Surprise maximisation and 
Infomap methods) produced clusters of upregulated adhesome proteins in 
Met1 which were distinct from clusters of upregulated adhesome proteins in 
Met4.  This community structure is indicative of differentially regulated 
molecular processes between the Met1 and Met4 at the adhesome level. 
 
However, different community detection algorithms all produced different 
communities with different sizes (a resolution problem), which hampered the 
subsequent gene ontology enrichment analysis to identify the differentially 
regulated molecular processes in Met1 and Met4.  Even for algorithms which 
seek communities based on similar ideas, the difference is the way they do 
it144.  For instance, both the Louvain method and the spectral modularity 
optimisation method seek to optimise the same quality function (i.e Girvan 
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Newman modularity) but they do it differently.  The Louvain method uses an 
agglomerative approach, while the spectral modularity optimisation method 
uses linear algebra to find community structures.  The specific procedures 
affect the reliability of the results as exemplified by the resolution problem.  It 
is true that one can assess the accuracy of the communities using an 
artificial network models with known community structures (artificial 
benchmark), however, artificial benchmarks do not properly describe real 
networks144 ( the active module is an example of a real network).  Thus, 
community detection methods that perform well on artificial benchmarks are 
not guaranteed to provide reliable solutions when applied to real networks.  
In addition to the resolution problem, real networks have specific features for 
which the methods used cannot accommodate.  For instance, the active 
module may have overlapping communities, but the methods used here will 
only partition the active module into non-overlapping communities.  However, 
we circumvent this by looking at the structural roles of the proteins in the 
communities, which may indicate the proteins (kinless proteins) that are likely 
to be in overlapping communities.  Moreover, the community detection 
methods used here have the advantage of allowing for communities to be 
observed despite the interaction network being incomplete.  This is because 
the methods used integrate the dynamics of the adhesome (e.g. the 
correlation between protein abundance) with the topology of the network. 
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Once community structures were defined, we proceeded with the 
identification of hubs in the active module.  We hypothesize that the kinless 
and connector hubs in the active module rewire to different proteins, leading 
to metastasis. Moreover, those hubs may be involved in the different 
molecular processes involved during cancer progression.  Here, we used the 
community-assisted approach as well as the direct approach to find hubs.  
Despite the identification of hubs being method dependent, we reasoned that 
hubs identified by multiple algorithms and by different approaches are more 
robust.  The community-assisted approach finds hubs according to their 
structural role with respect to the community structure.  The direct approach 
finds hubs based on properties from neighbouring nodes (e.g. PageRank).  
Thus, hubs which were determined by both the direct and community-
assisted approaches and occurred at least three times in the meta-
adhesome dataset were termed as consensus adhesome SCCs hubs 
(CASH). 
  
One such CASH was fibronectin, which was ranked first in the active module 
using the direct approach suggesting that it links highly connected protein 
clusters together.  This is unsurprising since Met1 and Met4 were seeded on 
fibronectin to induce the formation of the adhesome.  Being a kinless and a 
date hub, we speculate that fibronectin may be inducing different molecular 
pathways in Met1 and Met4. 
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RPA1 and XPO1 were the most frequent CASH to be identified by the 
different community detection algorithms.  Being kinless hubs suggests that 
RPA1 and XPO1 may be connecting different yet to be defined molecular 
processes during cancer progression.  Moreover, RPA1 and XPO1 were date 
hubs suggesting that they may be binding different proteins in primary and 
metastatic SCC cells.  We show that RPA1 and XPO1 have putative 
interactions with adhesome proteins that are upregulated in Met1 as well as 
with adhesome proteins that are upregulated in Met4.  Interestingly, XPO1 
putatively interacts with canonical focal adhesion components paxillin, Mena 
(ENAH), integrin linked kinase (ILK) and TRIP6.  Whether those putative 
interactions change during cancer progression still needs to be determined.  
It is tempting to speculate that XPO1 interacts with paxillin and ILK in primary 
cells but rewires to Mena and TRIP6 during metastasis.  Co-
immunoprecipitation of XPO1 with Mena, ILK, TRIP6 and paxillin in Met1 and 
Met4 cells should validate this hypothesis.  This will be carried out in future 
work. 
 
It has been reported that interactors of date hubs are diverse in spatial 
localisation within the cell98.  This is true for interactors of XPO1, which 
mediates the export of proteins from the nucleus to the cytoplasm.  Thus, 
interactors of XPO1 would be in at least two compartments within the cell 
namely the nucleus and the adhesome (or at the very least the cytoplasm).  
Interestingly, canonical focal adhesion components paxillin, ILK and TRIP6 
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were previously described to be in the nucleus156-162 , whereas Mena was 
not.  Since proteins that are close to one another in the interactome network 
have been shown to share similar functions163-165, the association of Mena 
with XPO1 suggests that Mena may also shuttle to the nucleus.  This 
hypothesis was investigated in chapter 5. 
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<Introduction 
In chapter 4, we identified exportin-1 (XPO1) as a hub in the adhesome 
network of patient-derived squamous cell carcinoma (SCC) cells that may 
interact with different molecular processes during cancer progression.  
Interestingly, network analysis of the SCC adhesome revealed a putative 
interaction between XPO1 and Mena, which is part of the actin-regulatory 
Ena/VASP proteins family.  The Ena/VASP proteins family consists of Evl, 
VASP and Drosophila Enabled (Ena; Mena being the mammalian orthologue 
of Ena).  The members of the Ena/VASP protein family share three 
conserved domains: an EVH1 domain at the N-terminus, an EVH2 domain at 
the C-terminus and a proline-rich region in-between the EVH1 and EVH2 
domains.  An additional domain consisting of LERER repeats is unique to 
Mena. 
 
Three isoforms, namely hMena, hMena11a and hMenaDv6 have been 
characterised in human cancer cells.  hMena is the ‘consensus’ human 
homologue of murine Mena and shares 87% identity with the latter49.  hMena 
consists of 570 amino acids encoded by 14 exons49.  The hMena11a variant 
has an extra exon of 63 nucleotides between exon 11 and exon 12, resulting 
in the addition of 21 amino acids in the EVH2 domain.  hMena11a is 
associated with epithelial phenotypes52 and p42/p44 mitogenic activity51.  
However, hMena11a suppresses invasion in vivo48.  The hMenaDv6 variant 
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lacks exon 6, which encodes for 37 amino acids between the LERER repeat 
domain and the proline-rich domain.  hMenaDv6 expression is associated 
with mesenchymal markers such as N-cadherin and vimentin expression52.  
Cells transfected with hMenaDv6 has an increased invasiveness through 
Matrigel52.  In addition, MenaINV is a murine isoform of Mena containing an 
INV exon (previously known as the +++ exon), which confers a 19-amino 
acid residue insertion just after the EVH1 domain.  MenaINV was found to be 
expressed in human invasive ductal carcinomas50, but all of MenaINV 
functional studies were performed on murine models.  
 
Mena expression is clinically associated with invasive cancers, regardless of 
the different hMena isoforms.  Immunohistological staining for pan-hMena 
was positive in infiltrating ductal carcinomas of the breast52, and in metastatic 
breast cancer53.  Mena overexpression was also reported in metastases of 
breast cancer (lymph nodes, lung, bone, brain, pleura)53.  hMena was 
overexpressed in colorectal adenomatous polyps with high dysplasia54 and 
invasive cervical squamous cell carcinomas56.  Moreover, pan-hMena 
expression was positively correlated with tumour size, proliferation index as 
evaluated by Ki67 staining, Her2 overexpression and cancer stage in breast 
cancer53.  In colorectal carcinoma, Mena expression correlated with vascular 
invasion, tumour budding, tumour stage, Her-2 and p53 expression54,55,166.  
Likewise, Mena expression was correlated with tumour grade of cervical 
intraepithelial lesion56.   
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Numerous studies have shown that MenaINV confers metastatic and motility 
properties in vivo and in vitro.  Rat mammary adenocarcinoma cells 
expressing MenaINV were reported to be more sensitized to epidermal 
growth factors (EGF), thereby promoting chemotaxis at extremely low 
concentration of EGF167.  MenaINV also promoted multicellular streaming in 
vivo, which is dependent on a paracrine signalling loop with macrophages48.  
Moreover, MenaINV-expressing cells have a higher ability to intravasate, and 
the presence of macrophages potentiates these cells to undergo 
transendothelial migration48,57.  Consistent with these findings, sections of 
human invasive ductal carcinomas of the breast with high immunohistological 
Mena staining were associated with perivascular macrophages48. 
 
Here, we report a novel function of Mena at the perinuclear region of 
metastatic human SCC cells. 
<Results 
Mena is highly abundant in the nucleus of patient-derived 
Met4 SCC cells 
XPO1 is a date hub (a hub that interacts with different binding partners under 
different conditions), which implies that interactors of XPO1 are diverse in 
spatial distribution within the cell.  Since XPO1 is a mediator of protein 
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nuclear export, interactors of XPO1 in the active module of the patient-
derived SCC cells adhesome network (the active module is the subnetwork 
of the adhesome network consisting of connected, differentially abundant 
adhesome proteins that may drive a metastatic phenotype) are expected to 
be in at least the nucleus and adhesion complexes.  Interestingly, XPO1 
interactors in the active module include the adhesome components paxillin, 
ILK, TRIP6 and Mena.  Paxillin, ILK and TRIP6 were previously reported to 
be in the nucleus, whereas Mena (ENAH) was not.  The association of Mena 
with XPO1 suggests Mena may also localise to the nucleus.  To test this 
hypothesis, subcellular fractionation using a sucrose cushion was performed 
on patient-derived Met1 and Met4 SCC cells, and the nuclear and 
cytoplasmic fractions were probed for Mena (Figure 29).  The abundance of 
Mena in the nucleus was higher in Met4 cells than Met1 cells.  Furthermore, 
it was observed that Met4 cells express mainly a doublet Mena band, while 
Met1 cells express one Mena band.  The observed doublet in Met4 cells 
could arise from serine/threonine de-phosphorylation of Mena168 or from 
expression of different Mena isoforms as observed in metastatic cells47,52.  
The nature of the Mena doublet in Met4 cells is yet to be determined. 
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Figure 29 Western blot showing the total cell lysate, nuclear and cytoplasmic fractions 
of Met1 and Met4 after sucrose cushion fractionation.  Mena was highly abundant in the 
nuclear fraction of Met4 compared to Met1.  Lamin A/C and Histone H3 are nuclear 
markers, GAPDH is a cytosolic marker and calnexin is an endoplasmic reticulum 
marker.  Western blot is representative of two experimental replicates. 
 
Mena nuclear translocation is matrix dependent and FAK 
mediated 
To induce adhesion complex formation for the analysis of the SCC 
adhesome (see Optimised Adhesome Isolation Conditions), Met1 and Met4 
were seeded onto the extracellular matrix (ECM) protein fibronectin.  To test 
whether Mena nuclear translocation was mediated by fibronectin-dependent 
adhesion, Met1 and Met4 cells were seeded on Matrigel-, fibronectin- and 
poly-D-lysine-coated plates for 4 hours followed by sucrose cushion 
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collagen IV and laminin.  Matrigel and fibronectin both activate integrins 
thereby triggering a series of signalling events, though Matrigel and 
fibronectin might activate different sets of integrins.  Cells seeded on PDL are 
attached by electrostatic interaction and thus integrin-mediated adhesion 
signalling is minimal. 
 
In Met1 cells, the ECM composition had no effect on Mena nuclear 
abundance (Figure 30(a-b)).  By contrast, nuclear Mena abundance in Met4 
cells was reduced by approximately twofold when seeded on PDL (Figure 
30(c-d)).  This suggests that Mena nuclear translocation is dependent on 
integrin-mediated adhesion in Met4 cells but not in Met1 cells. 
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Figure 30 (a,c) Western blots showing the total cell lysate, nuclear and cytoplasmic 
fractions of (a) Met1 and (c) Met4 after seeding cells on Matrigel (Mtg), fibronectin (FN) 
and poly-D-lysine (PDL) followed by sucrose cushion fractionation.  Lamin A/C and 
Histone H3 are nuclear markers, GAPDH is a cytosolic marker and calnexin is an 
endoplasmic reticulum marker.  Western blots are representative of three independent 
experimental replicates. (b,d) Bar charts representing the quantification of the 
fractionation Western blot for nuclear Mena.  (b) No statistically significant change was 
observed in the abundance of nuclear Mena in Met1 cells (n=3, Welch’s t-test). (d) A 
two-fold reduction in nuclear Mena was observed when Met4 cells were seeded on poly-
D-lysine as compared to fibronectin (n=3, Welch’s t-test). 
 
To understand how integrin-mediated adhesion is involved in nuclear Mena 
translocation, FAK was knocked out using CRISPR-Cas9 in Met1 and Met4 
cells.  FAK is activated upon integrin-mediated adhesion and mediates the 
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region where the FAK guide RNA (gRNA) was targeted shows that hCas9 
nuclease activity induced deletion three nucleotides upstream of the PAM 
sequence (currently, sequencing data is only available for Met1) (Figure 
31(g)).   
 
To test whether FAK could mediate nuclear translocation of Mena, Mena was 
probed in the nuclear fraction of Met1 and Met4 cells expressing endogenous 
FAK or with FAK knocked out.  In Met1 cells, FAK knock-out increased 
nuclear Mena abundance, though the increase was not statistically significant 
(Figure 31(a,b)).  Conversely, FAK knock-out in Met4 cells reduced nuclear 
Mena abundance by half (Figure 31(c,d)).  This suggests that FAK mediates 
Mena nuclear localisation, albeit differently in Met1 and Met4 cells. 
 
It was previously reported that FAK could mediate mechanosignalling 
through the FAK-Yap-mTor axis170 and the FAK-Src-PI3K pathway171.  To 
test whether FAK could mediate a similar process in the Met4 cells, we 
probed for nuclear Yap as a proxy for the mechanosignaling pathways in the 
nuclear fraction of Met1 and Met4 cells expressing endogenous FAK or with 
FAK knocked-out.  No change in nuclear Yap was observed upon FAK 
knock-out in Met4 cells (Figure 31(f)).  Conversely, in Met1 cells, FAK knock-
out did result in a reduction of nuclear Yap (Figure 31(e)).  This suggests that 
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Mena nuclear shuttling is unlikely to be mediated by the mechanosignalling 
axis of FAK. 
 
 
Figure 31 (a,c) Western blots showing the total cell lysate, nuclear and cytoplasmic 
fractions of (a) Met1 and Met1 FAK knock-out (Met1 FAK-/-) cells, and (c) Met4 and Met4 
FAK knock-out (FAK -/-) cells.  Histone H3 (His H3) is a nuclear marker, tubulin is a 
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representative of three independent experimental replicates.  (b,d,e,f) Bar charts 
representing the quantification of the fractionation western blots for (b,d) nuclear Mena 
and (e,f) nuclear Yap.  (b) No statistically significant change was observed in the 
abundance of nuclear Mena in Met1 and Met1 FAK knock-out cells.  (n=3, Welch’s t-
test).  (e) However, FAK knock-out resulted in a two-fold reduction in nuclear Yap.  (n=3, 
Welch’s t-test). (d) A two-fold reduction in nuclear Mena was observed when FAK was 
depleted in Met4 cells (n=3, Welch’s t-test).  (f) No change in nuclear Yap was observed 
upon FAK knock out in Met4 cells (n=3, Welch’s t-test).  (g) Genomic sequence of FAK 
exon 2 showing the specificity of FAK gRNA-hCas9-mediated nuclease activity.  As 
expected, the genome was cut three nucleotides upstream of the PAM sequence.  
 
FAK knock-out cells were obtained using one FAK gRNA only.  Thus, there is 
a possibility that the change in nuclear Mena could be due to non-specific 
targeting of the FAK gRNA to other proteins.  Thus, further validation needs 
to be carried out by re-expressing FAK in the FAK knock-out cells and test 
whether the observed change in nuclear Mena abundance is reversed.  
Moreover, the mechanism by which FAK mediates Mena nuclear 
translocation is yet to be determined, though it is unlikely to be mediated by 
the mechanosignalling axis of FAK. 
 
Mena export is mediated by XPO1 
Since Mena was highly enriched in the nuclear fraction of Met4 cells and 
XPO1 was isolated as part of the SCC adhesome complex, we asked 
whether the nuclear export of Mena was XPO1 dependent.  To test this, 
Met4 cells were treated with increasing concentrations (10nM and 20nM) of 
leptomycin-b (LMB), an inhibitor of XPO1, for 4 hours.  This was followed by 
subcellular fractionation using a mild detergent.  The nuclear and cytoplasmic 
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fraction were probed for Mena and p53, the latter being a positive control for 
LMB treatment172. 
 
Subcellular fractionation experiments showed increasing accumulation of 
nuclear Mena and p53 with increasing concentration of LMB (Figure 32).  
The increase in both nuclear p53 and Mena was statistically significant only 
when treated with 20nM LMB.  This suggests that XPO1 mediates the export 
of Mena from the nucleus. 
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Figure 32 Western blot showing the whole cell lysate (WCL), nuclear and cytoplasmic 
(Cyto) fractions of (a) Met4 cells treated with ethanol (control), 10nM and 20nM 
leptomycin-b (LMB) for 4 hours followed by sucrose cushion fractionation.  Histone H3 
(HisH3) is a nuclear marker, GAPDH is a cytosolic marker and calnexin is an 
endoplasmic reticulum marker.  Western blots are representative of three independent 
experimental replicates.   (b,c) Bar charts representing the quantification of (b) nuclear 
Mena and (c) nuclear p53.  (b) No statistically significant change was observed in the 
abundance of nuclear Mena when treated with 10nM LMB but a »2.5-fold increase in 
nuclear Mena was observed when Met4 cells were treated with 20nM LMB (n=3, one-
way ANOVA).  (e) As expected, nuclear p53 increases with increasing concentration of 
LMB (n=3, one-way ANOVA). 
 
In addition to the western blot analysis above, LMB-treated and non-treated 
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using spinning-disck confocal microscopy (SDCM).  Paxillin served as a 
positive control since it was previously observed that LMB treatment results 
in paxillin accumulation in the nucleus of mouse embryonic fibroblast cells173. 
 
An enrichment of Mena and paxillin (the latter as a positive control) in the 
nucleus was observed by immunofluorescence when Met4 cells were treated 
with 20nM LMB for 4 hours (preliminary result of a single experiment) (Figure 
33(a)).  The increase in the amount of nuclear Mena was modest compared 
to paxillin (Figure 33(b)).  Taken together, these results suggest that the 
nuclear export of Mena from the nucleus is XPO1 mediated. 
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Figure 33 (a) Spinning-disk confocal image of control Met4 cells and Met4 cells treated 
with 20nM leptomycin-b (LMB).  Cells were stained for paxillin (green) as a positive 
control for leptomycin-b treatment, Mena (red) and laminB1 (grey).  Image is 
representative of multiple images from one single experiment.  Scale bar = 10µm.  (b) A 
modest increase in the amount of nuclear Mena was observed (Control: n = 31 nuclei; 
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Mena is at the nuclear periphery and complexes with 
Nesprin-2 and actin 
Mena’s function as an actin regulator is well characterised40,43.  Since Mena 
was more abundant in the nuclear fractions of Met4 cells, we used these 
cells to gain insight into the biology of nuclear Mena.  In the SCC adhesome 
network analyses, Mena was in the same community as Nesprin-2, an actin-
binding protein of the LINC (Linker of Nucleoskeleton to the Cytoskeleton) 
complex, suggesting that Mena and Nesprin-2 may participate in the same 
molecular process.  To examine the localisation of Mena and Nesprin-2, they 
were immunostained in Met4 cells and filamentous actin (F-actin) was co-
stained by phalloidin.  Mena, Nesprin-2 and phalloidin were imaged by 
immunofluorescence using spinning-disk confocal microscopy (SDCM) and 
structured illumination microscopy (SIM). 
 
Interestingly, confocal microscopy revealed that Mena colocalised with 
Nesprin2 at the nuclear periphery (Figure 34(a)).  To determine whether 
Mena form complexes with Nesprin-2, the latter was immunoprecipitated 
from Met4 cell lysates and probed for Mena by western blot.  Mena co-
immunoprecipitated with Nesprin-2 (Figure 34(b)), indicating that Nesprin-2 
and Mena form a complex.  Orthogonal sections through a high-resolution 
SIM image revealed that Mena colocalises at the apical region of Nesprin-2 
staining, where actin filaments also colocalise (Figure 34(c)). 
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Figure 34 (a) Spinning disk confocal image of Met4 immunostained for Mena (green) 
and Nesprin-2 (magenta); F-actin is co-stained by phalloidin (cyan).  Scale bar = 10µm.  
Boxed region is shown on the right at 4x magnification.  Scale bar = 3µm.  Image is 
representative of two experimental replicates.  (b) Western blot analysis of shows Mena 
immunoprecipitates with Nesprin-2.  Western blot is representative of five independent 
replicates.  (c) Structured illumination microscopy immunostained for Mena (green) and 
Nesprin-2 (red); F-actin is co-stained with phalloidin (grey).  The orthogonal section 
through the white dashed line is shown on the right. Scale bar = 2.5µm.  Boxed region 
is shown below.  Mena and F-actin was found to co-localise at the apical tip of Nesprin-
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It was previously reported that actin filaments form stress fibres which bind to 
Nesprin-1 and Nesprin-2 and transmit tension to the nuclear lamina35.  Since 
Mena was observed to complex with F-actin and Nesprin-2, we asked 
whether Mena could mediate the interaction between actin and Nesprin-2 
and hence mediate the LINC complex interaction with lamin A/C.  To test this 
hypothesis, we generated a Mena knocked-out Met4 cell line using CRISPR-
Cas9.  Nesprin-2 was immunoprecipitated in Met4 cells expressing 
endogenous Mena and with Mena knocked-out, and the immunoprecipitates 
probed for actin and lamin A/C by western blot.  Preliminary results suggest 
that Mena depletion may result in reduced interaction between Nesprin-2 and 
actin and disrupts the interaction between Nesprin-2 and lamin A/C (Figure 
35(a)). 
 
Since Mena is involved in F-actin polymerisation, we estimated the effect of 
Mena depletion on actin filaments formation by staining for actin filaments 
using fluorophore phalloidin and measured the fluorescence intensity of 
phalloidin in Mena-expressing Met4 and Mena knock-out Met4 cells.  No 
change was observed in phalloidin staining in Mena knock-out cells 
compared to Mena-expressing cells (Figure 35(b,c)), suggesting that Mena 
actin polymerisation activity is redundant in Met4. 
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We also probed for phospho-myosin light chain but failed to obtain a positive 
band in neither Met4 expressing endogeneous Mena nor in Met4 with Mena 
knocked-out. 
 
These results suggest that Mena may play a role in force transmission 
through Nesprin-2 that may not involve its function in regulating actin filament 
formation and elongation.  However, further experiments are required to 
confirm this.  Mena needs to be re-expressed in the Mena-depleted cells to 
test whether the interaction between Nesprin-2 and actin can be rescued.  An 
F-actin/G-actin ratio assay will be performed to assess more accurately the 
effect of Mena on actin filament formation.  We also still need to assess the 
tension in the stress fibres in Mena depleted cells by using a phos-tag based 
analysis of phospho-myosin light chain as previously described174. 
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Figure 35 (a) Preliminary Western blot result of a single experiment showing reduction 
in the amount of actin and lamin A/C co-immunoprecipitated with Nesprin-2 upon Mena 
depletion in Met4 cells.  (b) Spinning-disk confocal image of Met4 cells expressing 
endogeneous Mena (Met4 End. Mena) and Met4 Mena knock-out cells (Met4 Mena -/-
(h3)) stained for F-actin (phalloidin, green) and nucleus (DAPI, blue).  (c) Bar chart 
representing the intensity of phalloidin staining in Met4 End. Mena (n = 8 cells) and Met4 
Mena knock-out cells (n = 19 cells). Error bars represent the standard deviation (no 
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Mena regulates global H3K27Me2 and EMERIN 
phosphorylation. 
It was previously reported that force transmission through the LINC complex 
results in the phosphorylation of its LEM- (Lap2, EMERIN, Man1) domain 
binding partner EMERIN38.  Since Mena is hypothesized to act as a clutch 
between Nesprin-2 and actin and thus mediates force transmission, we 
asked whether Mena may be involved in the phosphorylation of EMERIN.  To 
test this, EMERIN was probed in the phosphor-tyrosine (PY20) 
immunoprecipitates of Met4 cells expressing endogeneous Mena, Met4 cells 
with Mena knocked-out (transiently transfected with an empty cDNA vector 
as control) and Met4 Mena knock-out cells with transiently transfected 
Mena11a cDNA.  
 
Interestingly, Mena knock-out resulted in a reduction in phosphorylated 
EMERIN (pEMERIN) which was partially recovered upon Mena11a re-
expression (Figure 36(a,b)).  We did not observe complete recovery of 
pEMERIN despite an over-expression of Mena11a.  This is possibly due to 
the low efficiency of transient transfection whereby only a few cells were 
transfected with Mena11a cDNA plasmids.  It could also be due to the type of 
isoform being re-expressed.  Despite Mena11a seemingly migrating to a 
similar degree to the endogenous Mena in Met4 cells, hMena (11a exon 
missing) has previously been shown to co-migrate with Mena11a51.  Since 
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we do not know which isoform of Mena is being expressed in Met4 cells, it is 
possible that hMena may also be expressed.  Thus, it will be interesting to 
see whether a complete recovery of pEMERIN will be observed upon hMena 
re-expression as well as upon stable re-expression of Mena11a. 
 
EMERIN has previously been reported to anchor chromatin regions to the 
nuclear lamina (lamina-associated domains; LADs)175 which are associated 
with di-methylation of histone 3 on lysine 9 (H3K9Me2)37.  Moreover, it was 
previously reported that strain-induced perinuclear actin filament remodelling 
by EMERIN provides a switch from global di/tri-methylation of histone 3 on 
lysine 9 (H3K9Me2,3) to tri-methylation of histone 3 on lysine 27 
(H3K27Me3)5.  We thus asked whether the loss of Mena could affect histone 
methylation.  Interestingly, preliminary data suggests that Mena depletion 
results in a global increase in di-methylation of histone 3 on lysine 27 
(H3K27Me2) (Figure 36(c,d)).  Moreover, Met4 cells expressing endogenous 
Mena have strong H3K27Me2 staining along the edge of the nucleus (Figure 
36(c)).  Whether this region corresponds to LADs still remains to be 
determined.  Conversely, Mena-depleted Met4 cells have a more diffuse 
H3K27Me2 staining (Figure 36(c)).  The function of H3K27Me2 is not well 
understood but it has been reported that H3K27Me2 protects histone from 
H3K27 acetylation and thus prevents non-cell type specific enhancers from 
being activated176. 
 
Understanding the adhesome network in primary and metastatic cutaneous 
squamous cell carcinoma 
 From Bioinformatics to Bench: 
Mena has a nuclear function in Metastatic cells 
 
150 
Strain induces a global decrease in H3K9Me2,35.  Here, preliminary results 
suggest that Mena depletion induces a decrease in H3K9Me2 (Figure 36(c, 
e)).  H3K9Me2 is associated with LADs as well as heterochromatin (densely 
packed chromatin).  This result therefore suggests that Mena depletion may 
result in less densely packed chromatin.  Since both H3K27Me2 and 
H3K9Me2 are associated with transcription repression, we hypothesize that 
the increase in H3K27Me2 is a compensatory mechanism for loss in 
H3K9Me2 upon Mena depletion.  This hypothesis still needs to be tested by 
ChIP-Seq. 
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Figure 36 (a) Tyrosine phosphorylation of EMERIN is reduced upon Mena knock-out in 
Met4 cells and is partially rescued by transient transfection with Mena11a.  Western 
blots are representative of two independent replicates.  (b) Relative quantification of 
the EMERIN intensity in the western blots.  Error bars represent the standard deviation 
from the two independent replicates.  (c).  Spinning-disk confocal image of Met4 cells 
expressing endogenous Mena (Met4 End. Mena) and Met4 cells with Mena knock-out 
(Met4 Mena -/- (h3)), both immunostained for H3K27Me2 and H3K9Me2.  Representative 
image of a single experiment.  Scale bar = 10 µm.  (d) Mena depletion increased the 
intensity of H3K27Me2 staining (Met4 End. Mena, n = 41 nuclei; Met4 Mena -/-, n = 31 
nuclei; Mann-Whitney test, single experiment).  (e) Conversely, Mena depletion resulted 
in reduced H3K9Me2 staining (Met4 End. Mena, n = 52 nuclei; Met4 Mena -/-, n = 28 
nuclei; Mann-Whitney test, single experiment). 
 
Met4 Met4Mena -/- (h3)
cDNA Mena 11a ➖ ➖ ➕
Empty cDNA ➖ ➕ ➖
Met4 Met4 Mena -/- (h3)
➖ ➖ ➕ cDNA Mena 11a
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Here, we report a novel function of Mena in patient-derived SCC cells.  Our 
preliminary results suggest that Mena may act as a mechanosensor and/or 
as a scaffold at the perinuclear region. 
 
XPO1 was found to be an SCC adhesome hub which may connect different 
molecular processes during cancer progression.  Putative interactors of 
XPO1 from the SCC adhesion complex are canonical adhesion proteins, 
namely paxillin, ILK and TRIP6, and Mena.  We still need to validate the 
interactions of those canonical focal adhesion proteins with XPO1 in Met1 
and Met4 cells.  Paxillin, ILK and TRIP6 have previously been reported to 
have nuclear functions but Mena has not.  Thus, based on the prediction that 
interactors within network proximity have similar functions164, we asked 
whether Mena was also present in the nucleus of SCC cells.  Interestingly, 
Mena was indeed present in the nucleus and was more abundant in the 
nucleus of Met4 than in the nucleus of Met1.  As Met1 cells were derived 
from a primary SCC tumour and Met4 cells were derived from SCC 
metastasis from the same patient, this suggests that nuclear Mena may play 
a role in cancer progression. 
 
Mena nuclear translocation was found to be modulated by integrin-mediated 
cell adhesion in Met4 but not in Met1 cells.  Furthermore, FAK knock-out 
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reduced nuclear Mena abundance in Met4 but surprisingly increased nuclear 
Mena abundance in Met1 cells.  FAK has yet to be re-expressed in those 
FAK-depleted cell lines to confirm that nuclear Mena shuttling is FAK 
dependent and how FAK regulates Mena nuclear shuttling is yet to be 
determined.  We hypothesize that FAK may regulate Mena nuclear 
translocation by stabilising Mena at the focal adhesions. 
 
Inhibition of XPO1 in Met4 cells resulted in nuclear accumulation of Mena, 
confirming that Mena nuclear export is XPO1 dependent.  XPO1 has 
previously been isolated as part of the adhesome, though its function in the 
adhesome is currently unknown. 
 
In Met4 cells, Mena was associated with the perinuclear membrane, forming 
a complex with the outer-nuclear membrane protein Nesprin-2.  Mena 
depletion reduced the interaction of Nesprin-2 with actin as well as with lamin 
A/C.  Preliminary phalloidin staining results showed no change in F-actin 
formation between Mena-depleted Met4 and in Mena-expressing Met4 cells.  
Taken together, these results suggest that Mena may act as a molecular 
clutch with Nesprin-2 and actin, thereby mediating the force transmission 
through the LINC complex.  Further experiments are still required to validate 
this hypothesis: 1) determine the F-actin/G-actin ratio in Mena-expressing 
and Mena-depleted cells to assess more accurately the effect of Mena 
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depletion on F-actin formation, 2) rescue the interaction between Nesprin-2 
and actin by re-expressing Mena in Mena-depleted cells, 3) assess levels of 
phospho-myosin light chain to assess the effect of Mena depletion on actin 
stress fibre tension. 
 
It has previously been reported that tension applied to the LINC complex 
resulted in the phosphorylation of EMERIN38.  Mena depletion also resulted 
in a reduction of pEMERIN which was partially rescued upon transient 
Mena11a re-expression, consistent with the hypothesis that Mena mediate 
the force transmission through Nesprin-2.  However, we did not assess 
whether Mena depletion caused changes in tension along the stress fibres 
since we could not detect a positive band for phospho-myosin light chain in 
neither Mena-expressing Met4 nor in Mena-depleted Met4 cells. 
 
It was previously reported that EMERIN is mostly found at the outer nuclear 
membrane when the cells were under stress5.  Mena interacts with c-Abl, 
Src, PKA40,41, all of which have been reported to phosphorylate LEM domain 
proteins such as EMERIN177.  We hypothesize that Mena may also recruit 
those kinases to phosphorylate EMERIN present at the outer nuclear 
membrane.  It is plausible that the reduction of pEMERIN is due to a 
reduction in recruitment of those kinases at the nuclear periphery.  However, 
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immunoprecipitation of EMERIN in Mena-expressing and Mena-depleted 
Met4 cells is required to test this hypothesis. 
 
Depletion of Mena reduced global H3K9Me2 but conversely increased global 
H3K27Me2 levels. We hypothesize that the global increase in H3K27Me2 is 
a compensatory mechanism for the loss of H3K9Me2 upon Mena depletion.  
This needs to be validated by ChIP-Seq experiments to test whether gene 
enhancers or promoters occupied by H3K9Me2 has been replaced by 
H3K27Me2 upon Mena depletion.  A reduction in H3K9Me2 suggests 
decondensation of heterochromatin upon Mena depletion in Met4. 
 
Figure 37 gives a brief overview of the working model for Mena localisation 
and function in Met4 cells. 
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Figure 37 Summary diagram of the functions of Mena in Met4.  We hypothesize that 
Mena nuclear shuttling is regulated by FAK at the focal adhesion.  How FAK regulates 
Mena nuclear shuttling still needs to be determined.  Mena shuttles to the perinuclear 
region and complex with Nesprin-2 where Mena may act as a molecular clutch between 
the actin filaments and Nesprin-2.  This molecular clutch may transmit force through 
Nesprin-2 which results in the phosphorylation of EMERIN.  Furthermore, since EMERIN 
is mostly found at the outer nuclear membrane under tension, we also hypothesize that 
Mena may be recruiting kinases to phosphorylate EMERIN at the outer nuclear 
membrane.  However, we still need to test this hypothesis.  Mena may enter the nucleus 
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Interaction between cancer cells and the extracellular matrix is required for 
cancer progression.  Here, we aimed to study the adhesome in a cancer 
progression setting.  We isolated the adhesome from patient-derived 
squamous cell carcinoma (SCC) from the primary site (Met1) and secondary 
metastatic site (Met4).  We optimised the adesome isolation methodology for 
Met1 and Met4 and showed that adhesome proteins such as focal adhesion 
kinase (FAK), phosphorylated FAK, talin and aV-integrin were enriched while 
co-purifying contaminants such as nuclear proteins Histone H3, 
mitochondrial protein complex IV and cytosolic protein GAPDH were not 
isolated.  Fibronectin-induced adhesome consisting of 1941 proteins from 
Met1 and Met4 cells were identified by liquid-chromatography tandem mass-
spectrometry (LC-MS/MS).   
 
Changes in the adhesome between primary (Met1) and metastatic (Met4) 
SCC cells were captured by a protein-protein interaction network of 
differentially regulated adhesome proteins, called the active module.  
Interestingly, the active module has a modular structure (community 
structure) with coregulated adhesome proteins clustering among themselves.  
This modular structure is indicative of differentially regulated molecular 
processes between the Met1 and Met4 at the adhesome level.  These 
putative molecular processes could potentially be driving cancer progression 
at the adhesome level.  Future work involves the identification of these 
molecular processes by gene ontology enrichment. 
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Hubs identification using direct and community-assisted approaches were 
used to identify and prioritise essential proteins in those putative molecular 
processes.  Exportin-1 (XPO1) was recurrently identified as one of the 
essential hubs that may be driving cancer progression at the adhesome 
level.  Interestingly, XPO1 was also isolated in other fibronectin-induced 
adhesome though its function there is not yet known68.  XPO1 had putative 
interactions with canonical focal adhesion components paxillin, Mena, 
integrin linked kinase (ILK) and TRIP6.  Whether those putative interactions 
change during cancer progression is yet to be determined.  It is tempting to 
speculate that XPO1 interacts with paxillin and ILK in primary cells but 
rewires to Mena and TRIP6 during metastasis.  Co-immunoprecipitation of 
XPO1 with Mena, ILK, TRIP6 and paxillin in Met1 and Met4 cells should 
validate this hypothesis. 
 
FAK knock-out in Met1 resulted in an increase in Mena nuclear localisation.  
Interestingly, Sathe et al.173 described a similar observation whereby FAK or 
vinculin knock-out resulted in increased paxillin nuclear translocation.  They 
thus postulated that FAK and vinculin stabilise paxillin at focal adhesions, 
thereby decreasing paxillin translocation to the nucleus.  We hypothesize that 
a similar mechanism may be involved for the Mena translocation to the 
nucleus in Met1.  Conversely, integrin activation and FAK are required for 
Mena nuclear localisation in Met4.  Here, we hypothesize that activation of 
integrin and presumably FAK allow for the formation of a Mena complex, 
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thereby enabling Mena nuclear transport.  This could provide a novel function 
for both integrin and FAK in metastasis. 
 
There are increasing evidence that that the nuclear localisation of focal 
adhesion components (e.g. paxillin, zyxin, FAK) have a role in 
carcinogenesis4,158.  Our preliminary results showed that Mena has a nuclear 
function in metastatic cells and may act as a molecular clutch with Nesprin-2 
and actin, thereby mediating the force transmission through the LINC 
complex.  Two human Mena isoforms namely hMena11a and hMenaDv6 
were previously characterised in human cancers, with hMenaDv6 conferring 
an invasive potential to metastatic cells while hMena11a was associated with 
epithelial phenotypes52 and MAPK mitogenic activity51.  Moreover, hMena11a 
suppresses invasion in vivo48.  The Mena isoforms expressed in Met1 and 
Met4 has yet to be determined.  Nevertheless, hMena11a seems to migrate 
to a similar degree to endogenous nuclear Mena in Met4, suggesting that 
Mena11a may be present in the nucleus of metastatic cell line.  We 
speculate that Mena11a may confer cell growth and/or cell survival to Met4 in 
the lymph node. 
 
It has previously been reported that tension applied to the LINC complex 
resulted in the phosphorylation of EMERIN38.  Mena depletion also resulted 
in a reduction of phosphorylated EMERIN which was partially rescued upon 
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transient Mena11a re-expression, consistent with the hypothesis that Mena 
mediate the force transmission through Nesprin-2.  This force transmission 
could be tested using Nesprin-2 FRET probes as previously described178.  
However, we have yet to assess whether Mena depletion caused changes in 
tension along the stress fibres. 
 
It was previously reported that EMERIN is mostly found at the outer nuclear 
membrane when the cells were under stress5.  Mena interacts with c-Abl, 
Src, PKA40,41, all of which have been reported to phosphorylate LEM domain 
proteins such as EMERIN177.  We hypothesize that Mena may recruit those 
kinases to phosphorylate EMERIN present at the outer nuclear membrane.  
Future works would involve immunoprecipitation of EMERIN and assess the 
changes, if any, in the interaction between EMERIN and its kinases in Mena-
expressing and Mena-depleted Met4 cells. 
 
Our preliminary results suggest that the nucleus of Met4 cells may regulate 
histone modification by the mechanosensing activity of Mena at the nuclear 
periphery. Interestingly, it was previously reported that nuclear actin 
mediates a polycomb-mediated histone methylation switch5.  Therefore, it 
has been proposed that regulation of nuclear intake of G-actin by 
mechanosensing complexes at the nuclear periphery controls the 
transcriptional activity and levels of H3K27Me3.  Since Mena binds to G-actin 
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at its EVH2 domain, we therefore speculate that Mena may regulate the level 
of G-actin in the nucleus.  This will be tested by probing for actin in the 
nuclear fraction of Mena-expressing and Mena-depleted Met4 cells.  
Moreover, it has been suggested that the switching off of gene expression by 
histone modification drives cancer progression. It is thus tempting to 
speculate that Mena mediates cancer progression by maintaining H3K9Me2 
which prevents transcription activity179. 
Force transmission from the focal adhesion to the nucleus regulates gene 
transcription via genome reorganisation, transcription factors nuclear 
translocation and histone modification,  Although force transmission to the 
nucleus is known to require the use of the actin cytoskeleton, focal adhesion 
proteins and strain-maintaining proteins such as actomyosin, the role of actin 
regulating proteins in regulating force transmission to the nucleus was 
unknown.  Moreover, focal adhesion proteins are also observed at the 
nucleus but their roles at the nucleus are yet to be defined.  However, it is 
tempting to speculate that adhesion proteins can form complexes with the 
cytoskeleton at the nuclear membrane.  Moreover, the fact that nuclear 
confinement requires actin bundles suggest that in addition to filamentous 
actin180, actin binding proteins may also be required for filamentous actin 
coupling to the nucleus.  Our findings here provide a foundation for further 
studies in the role of actin regulating proteins at the nuclear periphery 
controlling metastasis. 
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